JP2015110631A - 糖尿病治療における優れた血糖コントロール - Google Patents
糖尿病治療における優れた血糖コントロール Download PDFInfo
- Publication number
- JP2015110631A JP2015110631A JP2015020034A JP2015020034A JP2015110631A JP 2015110631 A JP2015110631 A JP 2015110631A JP 2015020034 A JP2015020034 A JP 2015020034A JP 2015020034 A JP2015020034 A JP 2015020034A JP 2015110631 A JP2015110631 A JP 2015110631A
- Authority
- JP
- Japan
- Prior art keywords
- insulin
- composition
- minutes
- meal
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/545—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
Abstract
Description
インスリン関連障害のある患者において食後血糖変動を抑える方法を提供し、ここで食後血糖変動は、実質的に同様のインスリン曝露をもたらす皮下投与インスリンの用量より生じる食後血糖変動より小さく、ここで平均血糖変動は、皮下投与の場合より少なくとも約25%小さい。
本発明を説明する前に、下記に使用するいくつかの用語の理解を深めることは役に立つかもしれない。
糖尿病の治療用のインスリン療法に伴う一般的な問題は、食事グルコース負荷を制御するのに十分なインスリン用量が、食後に存続し得る延長期間の間に上昇するグルコース消失速度をもたらして、食後低血糖を導くことである。皮下投与後のインスリンの血中レベルの増加は、正常個体において見られる食事グルコースへの生理学的な応答より、糖尿病患者において有意に遅い。故に、血清インスリンレベルのより迅速な上昇をもたらしてから下降する、インスリンの組成物及び方法は、最大のグルコース消失速度を達成するためのより生理学的な手段をもたらす。このことは、投与されるインスリンの効果の大部分を食事付近の時間間隔へ圧縮して、それにより食後低血糖のリスクを抑えて、食事グルコースに対するより正常な生理学的インスリン応答をもたらす効果を有する。
これらには、量及び/又は時機にかかわらず、あらゆる栄養物の摂取も含まれる。
(実施例1)
(異なる用量レベルでのインスリン濃度は、線形吸収を示す)
様々な投与量のTechnosphere(登録商標)/Insulin(TI,MannKind Corporation)をヒト被検者へ投与して、血中インスリン濃度を測定した(図7A)。インスリン吸収は、AUCとして、少なくとも100U TIまでは投与量と比例した(図7B)。
(ヒトにおける初期相インスリン応答を迅速に生体利用される吸入インスリンで模倣すると、より遅いバイオアベイラビリティのインスリンに比較して、食後グルコース処理が加速される)
12名の2型糖尿病被検者の群において、等血糖クランプ(isoglycemic clamp)の間の時間、インスリン濃度、及びグルコース消失速度の間の関連性を試験した。各被検者は、24IU皮下インスリン(Actrapid(登録商標)、ノボ・ノルディスク)又は48U Technosphere(登録商標)/Insulin(TI)を別々の試験日に、クロスオーバー法で服用した。
(速いインスリンスパイクは、低血糖のリスクを高めない)
高濃度のインスリンは、特にその亢進効果と組み合わされると、グルコース消失速度をあまりに高く誘導して、低血糖を誘発する危険をもたらすと危惧されることだろう。しかしながら、事実はそうではない。正常血糖クランプ下の健常なヒト被検者に静脈内、皮下、又は肺へインスリンを与えて、投与後20分から始まる血中インスリン濃度に対してGIRをプロットした。正常被検者では、インスリンへ応答するGIRヒステレシスが、上記の実施例1に開示されるように、2型糖尿病患者よりずっと目立たない。このように、正常被検者では、インスリン投与後20分とそれ以降で、GIRとインスリン濃度の間の関係は、真の数学的な関数に近似する。より低いインスリン濃度では、その関数が直線的に見える一方で、より高い濃度の考察は、その関係が実際に対数的であることを示し、インスリン濃度が上昇するにつれて、GIRのさらに小さな増加が得られることが観察された(図15)。このように、グルコース消失は、破局的なほど高い速度に到達せず、そのようにすることができないように見えた。
(吸入Technosphere(登録商標)/Insulinの変動性及び時間−作用プロフィールは、皮下へのヒト標準インスリンのそれに対して好ましく比較される)
インスリンの代謝効果のタイミング及び再現性は、正常に近い血糖コントロールを達成して、患者と医師が適切な用量調整をすることを可能にするのにきわめて重要である。反復用量の48U吸入Technosphere(登録商標)/Insulin(TI)及び24IU皮下注射ヒト標準インスリン(SC)の間で、時間−作用プロフィールとインスリン吸収及びインスリン効果における患者内変動性を比較した。
(2型糖尿病患者における吸入Technosphere(登録商標)/Insulinの効果及び安全性に関する無作為化、二重盲検、プラセボ対照試験)
小さなMannKindTM吸入器より送達されるTechnosphere(登録商標)乾燥粉末肺インスリンは、正常な食事関連の第一相又は初期相インスリン放出を模倣するバイオアベイラビリティを有する。この多施設、無作為化、二重盲検、プラセボ対照試験は、食事又は経口剤療法で十分制御されない2型糖尿病患者(HbA1c>6.5%〜10.5%)において実施した。全部で123名の患者を登録し、119名の治療意思集団(ITT)を、6〜48の間の単位のヒトインスリン(rDNA起源)を含有する単位用量カートリッジ由来の食事吸入Technosphere(登録商標)/Insulin(TI)又は吸入Technosphere(登録商標)/プラセボを12週間受けるように、1:1の比で無作為化した。TIは、12週の試験を通して、1日の各主食又は主食相当食の最初1口の食事を摂るときに吸入して、1日につき3又は4回の投与に相当した。被検者は、試験に入る前に使用していたどんな経口糖尿病薬でも継続した。最初と最後の治療通院からのHbA1cの差異と最初の通院と2回の中間通院の間の差異を、
血糖の変化として、様々な時点のAUCと、食事チャレンジ後のCmax及びTmaxとして定量した。
(FDKP/Insulinは、食事開始の10分前〜30分後に投与するときに血糖コントロールを提供する)
乾燥粉末としてのFDKP−インスリン複合体(FDKP/Insulin;Technosphere(登録商標)/Insulin,TIとも呼ぶ)の肺投与のタイミングの効果を評価するために臨床治験を実施した。被検者は、その糖尿病の治療にインスリン以外の薬物も、炭水化物代謝に影響を及ぼす他の薬物も服用していない1型糖尿病患者であった。この治験は、前向き、単一施設、無作為化、クロスオーバー、オープンラベル試験であった。それぞれ8回の治療通院時に、ヒト被検者は、1回の個別用量を、等カロリー食(I;ほぼ500キロカロリー)又は高カロリー食(H;ほぼ720キロカロリー)の摂取の10分前(B10)、直前(C0)、15分後(A15)、又は30分後(A30)に吸入した。各被検者は、別々の時機にランダムな順序で、治療通院の間は1〜14日経過して、8種の可能な投与タイミング/食事の組合せ(即ち、B10I、B10H、C0I、C0H、A15I、A15H、A30I、及びA30H)のいずれかを受けた(図20を参照のこと)。TIの吸入と食事消費の前と後で採取した血液試料を使用して、
グルコースとインスリンの薬物動態変数を決定した。
IU用量=(BE*Fi)/0.30
[ここで:
IU用量は、投与するTIのIU数である。
BE(Brot−Einheit,パン単位)は、消費する食事の炭水化物含量(グラム)の1/10である(等カロリー食と高カロリー食で、それぞれ5と8.5)。
Fiは、1BEを受けるのに必要とされるインスリンの単位に等しい、個別のインスリン因子である。
0.30は、TIバイオアベイラビリティの相関因子である]。
食事消費の開始後の最高(Cmax)及び最低(Cmin)血糖濃度(ベースライン値に対して補正する)。
AUC:食事開始10分前〜食事開始後240分
AUC1:10分前〜TXまで、及び
AUC2:TX〜食事開始後240分まで。
それらはより早く起こり(Tmin3〜5分)、そしてそれらは、より短時間であった(ほぼ6〜7分)。血糖の最大の個別低下があったのは、等カロリー食又は高カロリー食の消費の直前にTIを吸入した被検者である(それぞれ、Cmin−58mg/dL及び−57mg/dL)。
血清インスリン濃度は下降し、後期T50%は33〜43分に及び、ここでもTIの吸入時間や食事タイプと首尾一貫した変動を示さなかった(表8)。
(ジケトピペラジン肺投与製剤におけるインスリンのバイオアベイラビリティ)
被検者と方法
本試験は、5名の男性ボランティアを用いて実施した。包含基準は、良好な健康(身体検査により判定する)、年齢:18〜40歳、ボディマス指数:18〜26kg/m2、4L/秒以上のピーク呼吸フローに達する能力(コンピュータ支援肺活量測定により測定する)、及び予測正常値の80%以上のFEV1(FEV1=1秒努力呼気量)であった。除外基準は、1若しくは2型糖尿病患者、ヒトインスリン抗体の罹病性、試験医薬品又は類似化学構造の薬物に対する過敏症の既往歴、重症アレルギー又は多重アレルギーの既往歴、試験エントリー前3ヶ月での他の治験薬での治療、進行性の致命的な疾患、薬物又はアルコール乱用の既往歴、他の薬物で薬物療法を受けていること、重大な心臓血管系、呼吸系、胃腸、肝臓、腎臓、神経系、精神医学系、及び/又は血液疾患の既往歴、進行性の気道感染症、明白な喫煙者又はタバコ又はニコチン使用の既往歴ありと判定される被検者であった。
試験日の朝、被検者(夜中から水以外は絶食)は午前7:30に来院した。被検者には、各処置日の24時間前から、過度の身体活動とアルコールの摂取を制限した。彼らを3つの処置アームの1つへ無作為に割り当てた。被検者は、0時点の前の2時間の間、血清インスリン濃度が10〜15μU/mLで確立されるように、0.15mU分−1kg−1に保つ一定の静脈内標準ヒトインスリン注入を受けた。この低用量注入を試験全体で継続して、内因性インスリン分泌を抑制した。血糖は、このグルコースクランプを通して、グルコース制御注入システム(BiostatorTM)により90mg/dLのレベルで一定に保った。グルコースクランプのアルゴリズムは、実際に測定される血糖濃度と、血糖濃度を一定に保つためのグルコース注入速度を計算する前の数分における変動性の度合いに基づいた。インスリンの適用(5IU IV又は10 IU SCの注射、又はカプセルにつき3回の深呼吸での吸入(各50Uで2つのカプセル)、市販の吸入デバイス(ベーリンガー・インゲルハイム)で適用する)は、0時点の直前に終了させなければならなかった。クランプ実験の時間は、0時点から6時間であった。グルコース注入速度、血糖、血清インスリン、及びCペプチドを測定した。
生体効果を定量するために、グルコース注入速度の曲線下面積を投与後最初の3時間(AUC0−180)と投与後6時間の全観察期間(AUC0−360)について計算して、適用したインスリンの量へ関連づけた。バイオアベイラビリティを定量するために、インスリン濃度の曲線下面積を投与後最初の3時間(AUC0−180)と投与後6時間の全観察期間(AUC0−360)について計算して、適用したインスリンの量へ関連づけた。
薬物動態の結果を図23及び24と表9に図示する。
100UのTIの吸入は、インスリン濃度のピークを13分後に(静脈内(IV)(5IU):5分、皮下(SC)(10IU):121分)、そしてインスリンレベルのベースラインへの復帰を180分後に(IV:60分、SC:360分)示した。グルコース注入速度により測定される生物学的作用は、39分後に(IV:14分、SC:163分)ピークになり、360分より多く(IV:240分、SC:>360分)続いた。絶対バイオアベイラビリティ(IV適用との比較)は、最初の3時間で14.6±5.1%であり、最初の6時間で15.5±5.6%であった。相対バイオアベイラビリティ(SC適用との比較)は、最初の3時間で25.8±11.7%であり、最初の6時間で16.4±7.9%であった。
Technosphere(登録商標)/Insulinは、すべての患者において安全であることが示された。1名の患者が吸入の間に咳をしていたが、さらなる症状も、呼吸系の悪化の徴候もなかった。
100UのTIの吸入は、十分忍容されて、達成された血清インスリン濃度から計算されるように、最初の3時間は25.8%の相対バイオアベイラビリティで実質的な血糖低下効果を有することが証明された。
本試験において、TIの吸入が、健常なヒト被検者において、インスリン濃度の迅速なピーク(Tmax:13分)と迅速な作用発現(Tmax:39分)、並びに6時間以上にわたる持続作用を伴う時間−作用プロフィールを有することが証明された。100UのTIの吸入後に測定された全代謝効果は、10IUのインスリンの皮下注射後より大きかった。TIの相対的な生体効果が19.0%であると計算された一方で、相対バイオアベイラビリティは、最初の3時間で25.8%であると定量された。
(食事のTechnosphere(登録商標)/Insulinは、食事の皮下インスリンより有意に優れた食事関連血糖変動のコントロールを提供する)
Technosphere(登録商標)/Insulin(TI)は、フマリルジケトピペラジン微粒子へ複合したインスリンを含んでなる、ヒトインスリンの乾燥粉末製剤である。乾燥粉末吸入器(MedTone(登録商標)Inhaler)を用いた肺投与によりTechnosphere(登録商標)/Insulinを送達して、迅速な作用発現と食事関連のグルコース吸収を受けるのに十分長い作用時間を達成した。本試験の主要目的は、食事前投与TIの安全性と血糖濃度に対する効力を7日の治療期間にわたり皮下(SC)標準インスリンに比較して評価することであった。
(2型糖尿病の被検者における、SC注射標準インスリンと比較した、吸入Technosphere(登録商標)/Insulinによる食後血糖変動の顕著な低下−ANOVAを用いた実施例8データの再解析)
ベースライン補正した食後の全インスリン曝露(INS−AUC0−240分)は、TIとSCで同等であった(8187±4269に対して8302±4025分*μU/dL;ns)が、TIのベースライン補正した食後血糖変動(BG−AUC0−240分)は、SCの約50%にすぎなかった(5095±5923分*mg/dLに対して9851±5593分*mg/dL;p<0.008)。このように、上記単位でのインスリン曝露に対する血糖変動の比(吸収されるインスリン用量の有効性の指標)は、TIでは約0.62でしかなかったのに対して、SCでは約1.2であった。言い換えると、吸収されるインスリンの単位あたりで見て、血液からグルコースを除去することにおいて、TIは、ほぼ2倍効率的であった。TIでは、SCよりメジアンインスリンTmaxがより短く、(15分対120分;p<0.001)、メジアンCmaxはより高かった(100μU/mL対54μU/mL;p=0.001)。従って、食後最高値で補正した血糖変動は、SCに比較してTIで28%低かった(49mg/dL対82mg/dL;p<0.003)。低血糖の発症(BG<63mg/dL、又は低血糖症状)は、治療で生じた(軽度〜中等度)副作用の件数(5エピソード対4エピソード)と同じように、TIとSCの間で同等(6エピソード対5エピソード)であった。高血糖(BG>280mg/dL)は、TIでより頻繁に生じた(12エピソード対4エピソード)が、2名の患者だけで8回のエピソードであった。
(通院状況において食事TIを受ける2型患者の多施設試験)
Technosphere(登録商標)/Insulin(TI)を使用する肺吸入により標準ヒトインスリンを投与する薬物動態および薬力学試験は、最高血漿インスリン濃度を吸入後約10〜14分のメジアンで達成することができて、これは第一相インスリン放出を再現するのに理想的であることを示した。このきわめて再現可能な動態プロフィールのインスリンを通院患者へ投与することは、現在利用可能な他のインスリンシステムでは可能でなかった。上記の実施例のような試験は、食前に与える皮下インスリン(SC)の生体利用可能な同等量に比較して、TIでの食後血糖変動が48%低下したことを実証した。通院状況において食事TIを12週間受ける2型患者の別の多施設試験では、前向きにモニタリングした低血糖の頻度が、通院使用のSCでこれまで報告されている頻度の10%未満であった。
(基礎/食事治療方式における食事インスリンとしての吸入Technosphere(登録商標)/Insulin又はSC投与速効性インスリン類似体の1型糖尿病患者での3ヶ月比較)
本試験は、Technosphere(登録商標)/Insulin(TI)を比較対照としての速効性インスリン類似体(RAA,Novolog(登録商標))と比較する、1型糖尿病患者の長期コントロールの一次評価を表す。TIのこれまでの試験では、2型糖尿病患者において240分にわたり標準ヒトインスリンより有意に優れた食後コントロールが示された。
続く3〜4時間にわたり、TI群では血糖がベースラインレベル付近で維持されたが、速効性インスリンを服用した患者では、ベースラインより下に下降した。HbA1cレベルでは、2つの治療群の間に有意差を観察しなかった。ベースラインからの低下は、TI群で0.83(1.11);p<001(平均(SD))、SCRAA服用群で0.99(1.07);p<0.001であり、群間に統計学的な差はなかった(p=0.458)。同時に、体重は、TI群で0.41(2.22)kg減少したが、SCインスリン服用群では0.89(1.92)kg増加した。群間の差は、統計学的に有意であった(p=0.0016)。TI服用被検者では、RAAに比較して、食後血糖変動の改善を観察した。通院10での最大食後変動は、TIで0.92ミリモル/Lに対し、RAAで3.0ミリモル/Lであった。全食後血糖上昇(AUCGLU)は、TIで96.7ミリモル/L*分であり、RAAで400.6ミリモル/L*分であった。3ヶ月の治療後に、肺機能に対する副作用は見られなかった(FEV1の変化は、TIで−0.064l(0.189)であり、RAAで−0.072(0.193)であり(p=0.82;n.s.)、そしてDLcoでは、それぞれ−1.62(3.29)と−1.094(3.08)(p=0.39;n.s.)であった)。故に、1型糖尿病患者の基礎/食事治療方式において、吸入TIは、SC投与RAAに対して好適な代替品であり、RAAに類似した全体血糖コントロール(ベースラインHbA1cからの変化として表される)を提供する一方で、食後変動は有意に小さかった。
限定ではなく、本発明の代わりの配置を本明細書の教示に従って利用してよい。従って、
本発明は、正確には、示して記載したものに限定されない。
本出願は、35U.S.C.§119(e)の下で、米国仮特許出願番号60/667,393(2005年3月31日出願)への優先権を主張して、米国特許出願番号11/329,686(2006年1月10日出願)の一部継続出願であり、このいずれもそのまま参照により本明細書に組み込まれる。
インスリン関連障害のある患者の治療に使用の医薬品の製造におけるインスリン組成物の使用であって、該組成物は、インスリン関連障害のある患者において、肺投与に適していて、食後血糖変動を抑えるために、長期作用型基礎インスリンと組み合わせて使用し、ここで臨床上重要な後期食後低血糖の発症は抑えられる、前記使用。
[付記2]
前記インスリン組成物を食事の開始近くで投与する、付記1に記載の使用。
[付記3]
前記インスリン組成物がジケトピペラジンとヒトインスリンの間の複合体を含む、付記1に記載の使用。
[付記4]
前記ジケトピペラジンがフマリルジケトピペラジンである、付記3に記載の使用。
[付記5]
前記インスリンを乾燥粉末として吸入により投与する、付記4に記載の使用。
[付記6]
前記インスリン組成物を食事の開始に先立つほぼ10分〜食事の開始後ほぼ30分に投与する、付記2に記載の使用。
[付記7]
前記インスリン関連障害が糖尿病である、付記1に記載の使用。
[付記8]
前記インスリン関連障害が2型糖尿病である、付記7に記載の使用。
[付記9]
前記インスリン関連障害が1型糖尿病である、付記7に記載の使用。
[付記10]
前記食後血糖変動が、実質的に同様のインスリン曝露をもたらす皮下投与インスリンの用量より生じる食後血糖変動より小さく、ここで平均血糖変動は、皮下投与の場合より少なくとも約25%小さい、付記1に記載の使用。
[付記11]
前記食後血糖変動が、インスリン単独の適正な皮下用量での治療により産生されるものより抑えられる、付記1に記載の使用。
[付記12]
前記臨床上重要な後期食後低血糖のエピソードの頻度が、インスリン単独の適正な皮下用量での治療に比べて抑えられる、付記1に記載の使用。
[付記13]
インスリン関連障害のある患者の治療に使用の医薬品の製造におけるインスリン組成物の使用であって、該組成物は、インスリン関連障害のある患者において、肺投与に適していて、食後血糖変動を抑えるために、長期作用型基礎インスリンと組み合わせて使用し、ここで患者の全インスリン曝露(INS−AUC0−y,3≦y≦6時間)は、インスリンの適正な皮下用量により産生されるものを実質的に超えず、そしてここで食後血糖変動は抑えられる、前記使用。
[付記14]
後期食後低血糖のリスクを高めない、付記13に記載の使用。
Claims (20)
- 長期作用型基礎インスリンと組み合わせてインスリン関連障害のある患者の治療に使用するためのインスリン組成物であって、該組成物は、肺投与に適していて、投与後15分以内にピークに到達し投与後80分以内に半最大値まで低下する血清インスリン濃度を前記患者にもたらし、前記患者の食後血糖変動を抑えるためのものであり、ここで臨床上重要な後期食後低血糖の発症は抑えられる、前記組成物。
- インスリン関連障害のある患者の治療に使用するためのインスリン組成物であって、該組成物は、肺投与に適していて、前記患者の食後血糖変動を抑えるために、長期作用型基礎インスリンと組み合わせて使用され、ここで患者の全インスリン曝露(INS−AUC0−y,3≦y≦6時間)は、インスリンの適正な皮下用量により産生されるものを超えず、そしてここで食後血糖変動は抑えられる、前記組成物。
- 前記インスリン組成物は、食事の開始近くで投与される、請求項1又は2に記載の組成物。
- 前記インスリン組成物が、食事の開始に先立つ10分〜食事の開始後30分に投与される、請求項1から3のいずれか1項に記載の組成物。
- インスリン関連障害のある患者の治療に使用するためのインスリン組成物であって、前記組成物は食事の開始に先立つ10分〜食事の開始後30分の間での前記患者への肺投与に適しており、前記組成物は、ジケトピペラジンとインスリンを含む微粒子であって、患者に投与された際に、投与後45分以内に最大グルコース排出速度をもたらす微粒子、及び/又は、投与後15分以内にピークに到達し投与後80分以内に半最大値まで低下する血清インスリン濃度をもたらす微粒子を含み、ここで、患者の全インスリン曝露(INS−AUC0−y,3≦y≦6時間)は、インスリンの適正な皮下用量により産生されるものと同様であり、食後血糖変動は抑えられる、前記組成物。
- インスリン関連障害のある患者の治療に使用するためのインスリン組成物であって、前記組成物は肺投与に適しており、前記組成物は、ジケトピペラジンとインスリンを含み、食事の開始に先立つ10分〜食事の開始後30分の間に投与された際に、投与後45分以内に最大グルコース排出速度をもたらし、グルコース排出速度が最大グルコース排出速度到達後80分以内に半最大値まで低下する、前記組成物。
- インスリン関連障害のある患者の治療に使用するためのインスリン組成物であって、前記組成物は肺投与に適しており、前記組成物は、ジケトピペラジンとインスリンを含み、食事の開始に先立つ10分〜食事の開始後30分の間に投与された際に、皮下投与インスリンより95%信頼区間でより低い変動係数のインスリン曝露(INS−AUC0−x,x≦3時間)又はグルコース消失((GIR−)AUC0−x,x≦3時間)をもたらし、ここで、全インスリン曝露[INS−AUC0−y,3≦y≦6時間]が同様である、前記組成物。
- インスリン関連障害のある患者の治療に使用するためのインスリン組成物であって、前記組成物は肺投与に適しており、前記組成物は、ジケトピペラジンとインスリンを含み、食事の開始に先立つ10分〜食事の開始後30分の間に投与された際に、同様のインスリン曝露を提供する用量のインスリンの皮下投与の場合より小さい、処置前HbA1cに対する処置後HbA1cの割合を示す、前記組成物。
- 投与後15分以内に最大血清インスリン濃度に到達する、請求項2及び6から8のいずれか1項に記載の組成物。
- 前記インスリン組成物がジケトピペラジンとヒトインスリンとの複合体を含む、請求項1から9のいずれか1項に記載の組成物。
- 前記ジケトピペラジンがフマリルジケトピペラジンである、請求項10に記載の組成物。
- 前記インスリンが、乾燥粉末として吸入により投与される、請求項11に記載の組成物。
- 後期食後低血糖のリスクが、インスリン単独の適正な皮下用量での治療と比較して、増加しない、請求項1から12のいずれか1項に記載の組成物。
- 後期食後低血糖のリスクが、インスリン単独の適正な皮下用量での治療と比較して、抑えられる、請求項1から13のいずれか1項に記載の組成物。
- 平均血糖変動は、皮下投与の場合より少なくとも25%小さい、請求項1から14のいずれか1項に記載の組成物。
- 前記インスリン関連障害が糖尿病である、請求項1から15のいずれか1項に記載の組成物。
- 前記インスリン関連障害が2型糖尿病である、請求項16に記載の組成物。
- 前記インスリン関連障害が1型糖尿病である、請求項16に記載の組成物。
- 一用量を投与した結果、前記一用量による処置前HbA1cに対する処置後HbA1cの割合が、前記一用量のインスリンの皮下投与の場合より、小さい、請求項1から18のいずれか1項に記載の組成物。
- インスリン関連障害のある患者の治療に使用の医薬品の製造における請求項1から19のいずれか1項に記載の組成物の使用。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66739305P | 2005-03-31 | 2005-03-31 | |
US60/667,393 | 2005-03-31 | ||
US11/329,686 US9006175B2 (en) | 1999-06-29 | 2006-01-10 | Potentiation of glucose elimination |
US11/329,686 | 2006-01-10 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008504512A Division JP5719099B2 (ja) | 2005-03-31 | 2006-03-31 | 糖尿病治療における優れた血糖コントロール |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016048575A Division JP2016147883A (ja) | 2005-03-31 | 2016-03-11 | 糖尿病治療における優れた血糖コントロール |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015110631A true JP2015110631A (ja) | 2015-06-18 |
JP2015110631A5 JP2015110631A5 (ja) | 2015-11-05 |
Family
ID=37054222
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008504512A Active JP5719099B2 (ja) | 2005-03-31 | 2006-03-31 | 糖尿病治療における優れた血糖コントロール |
JP2012238430A Expired - Fee Related JP5788374B2 (ja) | 2005-03-31 | 2012-10-29 | 糖尿病治療における優れた血糖コントロール |
JP2015020034A Pending JP2015110631A (ja) | 2005-03-31 | 2015-02-04 | 糖尿病治療における優れた血糖コントロール |
JP2016048575A Pending JP2016147883A (ja) | 2005-03-31 | 2016-03-11 | 糖尿病治療における優れた血糖コントロール |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008504512A Active JP5719099B2 (ja) | 2005-03-31 | 2006-03-31 | 糖尿病治療における優れた血糖コントロール |
JP2012238430A Expired - Fee Related JP5788374B2 (ja) | 2005-03-31 | 2012-10-29 | 糖尿病治療における優れた血糖コントロール |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016048575A Pending JP2016147883A (ja) | 2005-03-31 | 2016-03-11 | 糖尿病治療における優れた血糖コントロール |
Country Status (16)
Country | Link |
---|---|
US (6) | US9006175B2 (ja) |
EP (4) | EP2364717A1 (ja) |
JP (4) | JP5719099B2 (ja) |
KR (1) | KR101244028B1 (ja) |
CN (1) | CN101151047A (ja) |
AT (2) | ATE411040T1 (ja) |
AU (2) | AU2006230576B2 (ja) |
BR (1) | BRPI0608271A2 (ja) |
CA (1) | CA2601860C (ja) |
DE (2) | DE602006003228D1 (ja) |
DK (2) | DK1909826T3 (ja) |
ES (2) | ES2334258T3 (ja) |
HK (1) | HK1128876A1 (ja) |
IL (1) | IL186182A (ja) |
MX (1) | MX2007012102A (ja) |
WO (1) | WO2006105501A2 (ja) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
WO2001000654A2 (en) * | 1999-06-29 | 2001-01-04 | Pharmaceutical Discovery Corporation | Purification and stabilization of peptide and proteins in pharmaceutical agents |
US7464706B2 (en) | 1999-07-23 | 2008-12-16 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
US7305986B1 (en) | 1999-07-23 | 2007-12-11 | Mannkind Corporation | Unit dose capsules for use in a dry powder inhaler |
DE60318938T2 (de) | 2002-03-20 | 2009-01-22 | Mannkind Corp., Valencia | Inhalationsgerät |
US20070027063A1 (en) * | 2004-01-12 | 2007-02-01 | Mannkind Corporation | Method of preserving the function of insulin-producing cells |
EP1786784B1 (en) | 2004-08-20 | 2010-10-27 | MannKind Corporation | Catalysis of diketopiperazine synthesis |
CA2578175C (en) | 2004-08-23 | 2014-10-14 | Mannkind Corporation | Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery |
US7803404B2 (en) | 2005-09-14 | 2010-09-28 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces |
BRPI0707991B8 (pt) | 2006-02-22 | 2021-05-25 | Mannkind Corp | métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco |
US8785396B2 (en) | 2007-10-24 | 2014-07-22 | Mannkind Corporation | Method and composition for treating migraines |
CN101969927A (zh) * | 2007-10-24 | 2011-02-09 | 曼金德公司 | 预防glp-1不良影响的方法 |
CN101980743B (zh) * | 2008-03-27 | 2014-04-02 | 曼金德公司 | 干燥粉末吸入系统 |
AU2015201158B2 (en) * | 2008-03-27 | 2017-04-13 | Mannkind Corporation | A dry powder inhalation system |
EP2570147B1 (en) * | 2008-06-13 | 2017-10-18 | MannKind Corporation | A dry powder inhaler and system for drug delivery |
AU2014200952B2 (en) * | 2008-06-13 | 2014-12-11 | Mannkind Corporation | A dry powder inhaler and system for drug delivery |
AU2015275293B2 (en) * | 2008-06-13 | 2018-06-07 | Mannkind Corporation | A dry powder inhaler and system for drug delivery |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
US9364619B2 (en) * | 2008-06-20 | 2016-06-14 | Mannkind Corporation | Interactive apparatus and method for real-time profiling of inhalation efforts |
TWI614024B (zh) | 2008-08-11 | 2018-02-11 | 曼凱公司 | 超快起作用胰島素之用途 |
US11110151B2 (en) * | 2008-08-11 | 2021-09-07 | Mannkind Corporation | Composition and method for reducing hypoglycemia events in diabetes treatment |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
SI2379100T1 (sl) * | 2009-01-08 | 2015-02-27 | Mannkind Corporation | Zdravljenje hiperglikemije z GLP-1 |
WO2010089305A1 (en) * | 2009-02-04 | 2010-08-12 | Sanofi-Aventis Deutschland Gmbh | Medical device and method for glycemic control |
AU2014200960B2 (en) * | 2009-03-04 | 2016-02-11 | Mannkind Corporation | An improved dry powder drug delivery system |
TWI528982B (zh) * | 2009-03-04 | 2016-04-11 | 曼凱公司 | 改良的乾粉藥物輸送系統 |
PL2405963T3 (pl) | 2009-03-11 | 2014-04-30 | Mannkind Corp | Urządzenie, układ i sposób pomiaru oporu inhalatora |
KR20180079458A (ko) | 2009-06-12 | 2018-07-10 | 맨카인드 코포레이션 | 한정된 비표면적을 갖는 디케토피페라진 마이크로입자 |
MY172858A (en) * | 2009-06-12 | 2019-12-12 | Mannkind Corp | Diketopiperazine microparticles with defined isomer contents |
EP3533517A1 (en) | 2009-11-02 | 2019-09-04 | MannKind Corporation | Method for cryogranulating a pharmaceutical composition |
EP2496295A1 (en) | 2009-11-03 | 2012-09-12 | MannKind Corporation | An apparatus and method for simulating inhalation efforts |
RU2531455C2 (ru) | 2010-06-21 | 2014-10-20 | Маннкайнд Корпорейшн | Системы и способы доставки сухих порошковых лекарств |
CN105854136A (zh) | 2010-09-06 | 2016-08-17 | 奇斯药制品公司 | 计量剂量吸入器和使用该计量剂量吸入器的方法 |
CN105667994B (zh) * | 2011-04-01 | 2018-04-06 | 曼金德公司 | 用于药物药盒的泡罩包装 |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
AU2012328885B2 (en) | 2011-10-24 | 2017-08-31 | Mannkind Corporation | Methods and compositions for treating pain |
CN108057154B (zh) | 2012-07-12 | 2021-04-16 | 曼金德公司 | 干粉药物输送系统和方法 |
US20150231067A1 (en) * | 2012-08-29 | 2015-08-20 | Mannkind Corporation | Method and composition for treating hyperglycemia |
US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
WO2014152993A1 (en) * | 2013-03-14 | 2014-09-25 | The Board Of Regents Of The University Of Oklahoma | Use of klotho nucleic acids or proteins for treatment of diabetes and diabetes-related conditions |
CA2906817C (en) | 2013-03-15 | 2022-01-18 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
US9925144B2 (en) | 2013-07-18 | 2018-03-27 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
EP3030140B1 (en) * | 2013-08-05 | 2019-06-19 | Hygieia, Inc. | Systems and devices for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus |
JP2016530930A (ja) | 2013-08-05 | 2016-10-06 | マンカインド コーポレイション | 通気装置及び方法 |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
WO2017091484A2 (en) * | 2015-11-27 | 2017-06-01 | Dascena | Diagnostic System For Current And Future Patient Condition Determination |
CA3225148A1 (en) | 2016-05-19 | 2017-11-23 | Mannkind Corporation | Apparatus, system and method for detecting and monitoring inhalations |
US11013873B2 (en) * | 2017-01-06 | 2021-05-25 | HealthPartners Institite | Methods for treating patients with impaired awareness of hypoglycemia |
US20210220443A1 (en) * | 2018-06-18 | 2021-07-22 | Biocon Limited | Method and use of controlling postprandial glucose levels in a subject |
WO2020077030A1 (en) * | 2018-10-11 | 2020-04-16 | The Cleveland Clinic Foundation | Aggf1 and aggf1-primed cells for treating diseases and conditions |
CN111235036B (zh) * | 2020-01-15 | 2022-03-18 | 西北大学 | 一种冠突散囊菌及从其中分离纯化二酮哌嗪二聚体的方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003503420A (ja) * | 1999-06-29 | 2003-01-28 | ファーマシューティカル ディスカバリー コーポレイション | ペプチドおよびタンパク質の薬学的因子の精製および安定化 |
JP5788374B2 (ja) * | 2005-03-31 | 2015-09-30 | マンカインド コーポレイション | 糖尿病治療における優れた血糖コントロール |
Family Cites Families (1033)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB475440A (en) | 1935-09-23 | 1937-11-19 | Mine Safety Appliances Co | Improvements in or relating to apparatus for determining the flow resistance of breathing apparatus elements |
US2549303A (en) | 1949-04-20 | 1951-04-17 | Bristol Lab Inc | Inhaler for crystalline pencilllin or the like |
BE509861A (ja) | 1952-03-13 | |||
US2754276A (en) | 1953-02-12 | 1956-07-10 | Du Pont | Cellular compositions utilizing dinitrosopentamethylene-tetramine as the blowing agent |
US3337740A (en) | 1962-02-13 | 1967-08-22 | Deering Milliken Res Corp | Process for separating acrylic acid from impurities |
US4187129A (en) | 1962-05-14 | 1980-02-05 | Aerojet-General Corporation | Gelled mechanically stable high energy fuel composition containing metal platelets |
FR1451293A (fr) | 1964-05-18 | 1966-01-07 | Entoleter | Matière composite et son procédé de préparation |
US3407203A (en) | 1965-03-22 | 1968-10-22 | Union Carbide Corp | Novel process for the preparation of diketopiperazines |
US3669113A (en) | 1966-03-07 | 1972-06-13 | Fisons Ltd | Inhalation device |
US3518340A (en) | 1968-04-15 | 1970-06-30 | Dow Corning | Method of forming silicone rubber drug carriers |
US3622053A (en) | 1969-12-10 | 1971-11-23 | Schering Corp | Aerosol inhaler with flip-up nozzle |
US3673698A (en) | 1970-11-25 | 1972-07-04 | Albert S Guerard | Process for freeze drying with carbon dioxide |
BE794951A (fr) | 1972-02-03 | 1973-05-29 | Parke Davis & Co | Conditionnement soluble dans l'eau |
US3873651A (en) | 1972-05-12 | 1975-03-25 | Atomic Energy Commission | Freeze drying method for preparing radiation source material |
US3823843A (en) | 1972-10-26 | 1974-07-16 | Lilly Co Eli | Locking capsule |
US3856142A (en) | 1973-01-24 | 1974-12-24 | Mine Safety Appliances Co | Inhalant package |
FR2224175B1 (ja) | 1973-04-04 | 1978-04-14 | Isf Spa | |
US3980074A (en) | 1973-07-18 | 1976-09-14 | Beecham Group Limited | Device for the administration of powders |
GB1479283A (en) * | 1973-07-23 | 1977-07-13 | Bespak Industries Ltd | Inhaler for powdered medicament |
GB1459488A (en) | 1974-03-19 | 1976-12-22 | Wyeth John & Brother Ltd | Piperazinedione derivatives |
IT1017153B (it) | 1974-07-15 | 1977-07-20 | Isf Spa | Apparecchio per inalazioni |
US4018619A (en) | 1974-09-23 | 1977-04-19 | Iu Technology Corporation | Highly activated mixtures for constructing load bearing surfaces and method of making the same |
US4005711A (en) | 1975-01-13 | 1977-02-01 | Syntex Puerto Rico, Inc. | Inhalation device |
DE2502251A1 (de) | 1975-01-17 | 1976-07-22 | Schering Ag | Vorrichtung zur inhalation pulverfoermiger feststoffe |
US4040536A (en) | 1975-05-05 | 1977-08-09 | R. P. Scherer Corporation | Locking hard gelatin capsule |
BR7603665A (pt) | 1975-06-09 | 1977-02-01 | Nat Distillers Chem Corp | Processo para comunicar resistencia a aglomeracao a um polimero de etileno-acetano de vinila e o polimero resultant |
US4153689A (en) | 1975-06-13 | 1979-05-08 | Takeda Chemical Industries, Ltd. | Stable insulin preparation for nasal administration |
US3998226A (en) | 1975-09-22 | 1976-12-21 | Edward G. Gomez | Inhalation device for encapsulated concentrates |
GB1509979A (en) | 1975-11-28 | 1978-05-10 | Fisons Ltd | Pharmaceutical compositions containing aspirin or indomethacin |
US4102953A (en) | 1976-05-25 | 1978-07-25 | The United States Of America As Represented By The Secretary Of The Navy | Method for making extruded, solventless, composite-modified double base propellant |
USD252707S (en) | 1977-01-03 | 1979-08-21 | Joel Besnard | Inhaler |
GB1598081A (en) | 1977-02-10 | 1981-09-16 | Allen & Hanburys Ltd | Inhaler device for dispensing medicaments |
US4171000A (en) | 1977-03-23 | 1979-10-16 | Uhle Klaus P | Smoking device |
IE46865B1 (en) | 1977-04-29 | 1983-10-19 | Allen & Hanburys Ltd | Device for dispensing medicaments |
US4148308A (en) | 1977-05-31 | 1979-04-10 | Sayer William J | Mouthpiece with a tongue retractor |
US4110240A (en) | 1977-07-29 | 1978-08-29 | Wyrough And Loser, Inc. | Coprecipitation process |
US4091077A (en) | 1977-08-12 | 1978-05-23 | The United States Of America As Represented By The United States Department Of Energy | Process for recovering filler from polymer |
US4211769A (en) | 1977-08-24 | 1980-07-08 | Takeda Chemical Industries, Ltd. | Preparations for vaginal administration |
US4268460A (en) | 1977-12-12 | 1981-05-19 | Warner-Lambert Company | Nebulizer |
CA1113044A (en) | 1977-12-16 | 1981-11-24 | J. Paul Leblond | Personal repellant device |
US4356167A (en) | 1978-01-27 | 1982-10-26 | Sandoz, Inc. | Liposome drug delivery systems |
US4175556A (en) | 1978-04-07 | 1979-11-27 | Freezer Winthrop J | Inhaler with flow-through cap |
US4196196A (en) | 1978-06-19 | 1980-04-01 | Tiholiz Ivan C | Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states |
US4168002A (en) | 1978-08-03 | 1979-09-18 | Crosby Leslie O | Multiple-seed package card |
US4272398A (en) | 1978-08-17 | 1981-06-09 | The United States Of America As Represented By The Secretary Of Agriculture | Microencapsulation process |
DE2840442C2 (de) | 1978-09-16 | 1982-02-11 | C.H. Boehringer Sohn, 6507 Ingelheim | Verwendung des Diketopiperazins L-Leu-L-Trp als Geschmacksstoff für Getränke mit bitterer Geschmacksrichtung |
DE2849493C2 (de) | 1978-11-15 | 1982-01-14 | Carl Heyer Gmbh, Inhalationstechnik, 5427 Bad Ems | In der Hand zu haltender Aerosolspender |
USD269463S (en) | 1978-12-08 | 1983-06-21 | Fisons Limited | Container for a medicinal inhaler |
JPS6034925B2 (ja) | 1979-07-31 | 1985-08-12 | 帝人株式会社 | 持続性鼻腔用製剤およびその製造法 |
US4407525A (en) | 1979-10-04 | 1983-10-04 | Gao Gesellschaft Fur Automation Und Organisation Mbh | Identification card with hallmark for authentication by incident and transmitted light |
GB2072536B (en) | 1980-03-25 | 1983-12-07 | Malem H | Nebuliser |
US4289759A (en) | 1980-06-23 | 1981-09-15 | Ortho Pharmaceutical Corporation | Immunoregulatory diketopiperazine compounds |
EP0055537B1 (en) | 1980-12-12 | 1984-12-05 | Combi Co., Ltd. | Inhaler |
US4900730A (en) | 1981-01-14 | 1990-02-13 | Toyo Jozo Co., Ltd. | Preparation which promotes the absorption of peptides |
GB2092136B (en) | 1981-01-17 | 1985-06-05 | Mitsui Toatsu Chemicals | Production of n-substituted amide compounds |
JPS58140026A (ja) | 1982-01-14 | 1983-08-19 | Toyo Jozo Co Ltd | 吸収性良好な製剤 |
IT1220979B (it) | 1981-06-04 | 1990-06-21 | Lofarma Farma Lab | Capsule contenenti un allergene e procedimento per la loro preparazione |
CY1492A (en) | 1981-07-08 | 1990-02-16 | Draco Ab | Powder inhalator |
SE438261B (sv) | 1981-07-08 | 1985-04-15 | Draco Ab | Anvendning i dosinhalator av ett perforerat membran |
US5260306A (en) | 1981-07-24 | 1993-11-09 | Fisons Plc | Inhalation pharmaceuticals |
USD276654S (en) | 1981-09-15 | 1984-12-04 | Aktiebolaget Draco | Medical aerosol inhalation device |
KR890000664B1 (ko) | 1981-10-19 | 1989-03-22 | 바리 안소니 뉴우샘 | 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법 |
US4659696A (en) | 1982-04-30 | 1987-04-21 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition and its nasal or vaginal use |
US4483922A (en) * | 1982-05-14 | 1984-11-20 | Amf Inc. | Inactivation of enzymes |
US4526804A (en) | 1982-08-30 | 1985-07-02 | Ball Corporation | Method for providing sheet metal stock with finely divided powder |
US4487327A (en) | 1982-12-21 | 1984-12-11 | Grayson Robert E | Locking capsule |
JPS59163313A (ja) | 1983-03-09 | 1984-09-14 | Teijin Ltd | 経鼻投与用ペプチドホルモン類組成物 |
AU90762S (en) | 1983-06-29 | 1985-08-15 | Glaxo Group Ltd | Inhaler |
US4581020A (en) | 1983-07-18 | 1986-04-08 | Trimedyne, Inc. | Medication delivery device and system for percutaneous administration of medication |
GB8325529D0 (en) | 1983-09-23 | 1983-10-26 | Lilly Industries Ltd | Medicinal forms |
CH661878A5 (de) | 1983-11-04 | 1987-08-31 | Warner Lambert Co | Kapsel-dosierungsformen. |
USD295321S (en) | 1984-03-13 | 1988-04-19 | Glaxo Group Limited | Inhaler container for a medical aerosol |
JPS60248618A (ja) | 1984-05-24 | 1985-12-09 | Nippon Zoki Pharmaceut Co Ltd | ジペプチドを含有する潰瘍治療剤 |
US4927555A (en) | 1984-08-13 | 1990-05-22 | Colgate-Palmolive Company | Process for making thixotropic detergent compositions |
USD288852S (en) | 1984-08-29 | 1987-03-17 | Aruman Co., Ltd. | Disposable inhaler |
US4757066A (en) | 1984-10-15 | 1988-07-12 | Sankyo Company Limited | Composition containing a penem or carbapenem antibiotic and the use of the same |
IE58468B1 (en) | 1984-10-25 | 1993-09-22 | Warner Lambert Co | Method for sealing capsules and capsule |
US4592348A (en) | 1984-12-17 | 1986-06-03 | Waters Iv William C | Aerosol inhaler |
US4946828A (en) | 1985-03-12 | 1990-08-07 | Novo Nordisk A/S | Novel insulin peptides |
SE448277B (sv) | 1985-04-12 | 1987-02-09 | Draco Ab | Indikeringsanordning vid en doseringsanordning for lekemedel |
JPS6320301Y2 (ja) | 1985-04-18 | 1988-06-06 | ||
US5785989A (en) | 1985-05-01 | 1998-07-28 | University Utah Research Foundation | Compositions and methods of manufacturing of oral dissolvable medicaments |
US4615817A (en) | 1985-05-17 | 1986-10-07 | Mccoy Frederic C | Additives containing polytetrafluoroethylene for making stable lubricants |
CA1318730C (en) | 1985-05-30 | 1993-06-01 | C. Edward Capes | Method of separating carbonaceous components from particulate coal containing inorganic solids and apparatus therefor |
US5098590A (en) | 1988-02-04 | 1992-03-24 | Colgate Palmolive Co. | Thixotropic aqueous automatic dishwasher detergent compositions with improved stability |
NO166268C (no) | 1985-07-30 | 1991-07-03 | Glaxo Group Ltd | Innretning for administrering av medikamenter til pasienter. |
AT384552B (de) | 1985-08-01 | 1987-12-10 | Hurka Wilhelm | Inhalationsgeraet zur dosierung und verteilung von festkoerpern in die atemluft |
US4624861A (en) | 1985-09-05 | 1986-11-25 | Gte Products Corporation | Rare earth oxysulfide phosphors and processes for creating same |
PT83613B (en) | 1985-10-28 | 1988-11-21 | Lilly Co Eli | Process for the selective chemical removal of a protein amino-terminal residue |
EP0248051A1 (en) | 1985-11-29 | 1987-12-09 | FISONS plc | Pharmaceutical composition including sodium cromoglycate |
LU86258A1 (fr) | 1986-01-21 | 1987-09-03 | Rech Dermatologiques C I R D S | Composes benzamido aromatique,leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique |
SE453566B (sv) | 1986-03-07 | 1988-02-15 | Draco Ab | Anordning vid pulverinhalatorer |
US4849227A (en) | 1986-03-21 | 1989-07-18 | Eurasiam Laboratories, Inc. | Pharmaceutical compositions |
US5614492A (en) | 1986-05-05 | 1997-03-25 | The General Hospital Corporation | Insulinotropic hormone GLP-1 (7-36) and uses thereof |
US6849708B1 (en) | 1986-05-05 | 2005-02-01 | The General Hospital Corporation | Insulinotropic hormone and uses thereof |
US5120712A (en) | 1986-05-05 | 1992-06-09 | The General Hospital Corporation | Insulinotropic hormone |
US5118666A (en) | 1986-05-05 | 1992-06-02 | The General Hospital Corporation | Insulinotropic hormone |
US4926852B1 (en) | 1986-06-23 | 1995-05-23 | Univ Johns Hopkins | Medication delivery system phase one |
USD301273S (en) | 1986-07-10 | 1989-05-23 | Leonard G Darin | Hand held fly suction device |
JPS6320301A (ja) | 1986-07-11 | 1988-01-28 | Dainichi Color & Chem Mfg Co Ltd | キトサン微小粒体 |
US5042975A (en) | 1986-07-25 | 1991-08-27 | Rutgers, The State University Of New Jersey | Iontotherapeutic device and process and iontotherapeutic unit dose |
WO1988001165A1 (en) | 1986-08-11 | 1988-02-25 | Innovata Biomed Limited | Pharmaceutical formulations comprising microcapsules |
USRE35862E (en) | 1986-08-18 | 1998-07-28 | Emisphere Technologies, Inc. | Delivery systems for pharmacological agents encapsulated with proteinoids |
AU610083B2 (en) | 1986-08-18 | 1991-05-16 | Clinical Technologies Associates, Inc. | Delivery systems for pharmacological agents |
EP0257956B2 (en) | 1986-08-19 | 2000-11-22 | Genentech, Inc. | Use of polypeptide growth factors and cytokines for the manufacture of a device and of a dispersion |
DE3639836A1 (de) | 1986-11-21 | 1988-06-01 | Sigrid Bechter | Mundstueck fuer ein inhalationsgeraet |
KR890003520Y1 (ko) | 1986-12-20 | 1989-05-27 | 주식회사 서흥캅셀 | 의약용 캅셀 |
US4861627A (en) | 1987-05-01 | 1989-08-29 | Massachusetts Institute Of Technology | Preparation of multiwall polymeric microcapsules |
US4981295A (en) | 1987-05-11 | 1991-01-01 | City Of Hope | Respiratory training using feedback |
US6645504B1 (en) | 1987-06-24 | 2003-11-11 | Autoimmune Inc. | Bystander suppression of type I diabetes by oral administration of glucagon |
DE3727894A1 (de) | 1987-08-21 | 1989-03-02 | Stephan Dieter | Kapsel fuer pharmazeutisch wirksame inhaltsstoffe einer droge |
GB8723846D0 (en) | 1987-10-10 | 1987-11-11 | Danbiosyst Ltd | Bioadhesive microsphere drug delivery system |
US4887722A (en) | 1987-12-11 | 1989-12-19 | Greenward Sr Edward H | Method for beneficiating by carbonaceous refuse |
DE3801326A1 (de) | 1988-01-19 | 1989-07-27 | Asea Brown Boveri | Verfahren zur herstellung einer keramiksuspension |
US4981625A (en) | 1988-03-14 | 1991-01-01 | California Institute Of Technology | Monodisperse, polymeric microspheres produced by irradiation of slowly thawing frozen drops |
GB8813338D0 (en) | 1988-06-06 | 1988-07-13 | Osprey Metals Ltd | Powder production |
US4886051A (en) * | 1988-06-27 | 1989-12-12 | White Francis E | Massaging bed |
USD316902S (en) | 1988-09-02 | 1991-05-14 | Hoelfing H Curt | Meter hose inhaler reservoir |
GB8821287D0 (en) | 1988-09-12 | 1988-10-12 | Ici Plc | Device |
EP0360340A1 (en) | 1988-09-19 | 1990-03-28 | Akzo N.V. | Composition for nasal administration containing a peptide |
USD321570S (en) | 1988-09-30 | 1991-11-12 | Blasdell Richard J | Inhaler |
DE68914932T2 (de) | 1988-10-04 | 1994-08-11 | Univ Johns Hopkins | Inhalationsgerät für Aerosolen. |
US4984158A (en) | 1988-10-14 | 1991-01-08 | Hillsman Dean | Metered dose inhaler biofeedback training and evaluation system |
JPH02104531A (ja) | 1988-10-14 | 1990-04-17 | Toyo Jozo Co Ltd | 経鼻投与用生理活性ペプチド組成物 |
JPH02115154A (ja) | 1988-10-25 | 1990-04-27 | Kao Corp | イミド化合物及びその用途 |
USD326517S (en) | 1988-10-27 | 1992-05-26 | Glaxo Group Limited | Inhalator |
JP2692742B2 (ja) | 1988-11-30 | 1997-12-17 | 株式会社ツムラ | 新規なリグナン類 |
US5006343A (en) | 1988-12-29 | 1991-04-09 | Benson Bradley J | Pulmonary administration of pharmaceutically active substances |
US5075027A (en) | 1989-02-06 | 1991-12-24 | Colgate Palmolive Co. | Thixotropic aqueous scented automatic dishwasher detergent compositions |
US5514646A (en) | 1989-02-09 | 1996-05-07 | Chance; Ronald E. | Insulin analogs modified at position 29 of the B chain |
IT1228460B (it) | 1989-02-23 | 1991-06-19 | Phidea S R L | Inalatore monouso con capsula pre-forata |
IT1228459B (it) | 1989-02-23 | 1991-06-19 | Phidea S R L | Inalatore con svuotamento regolare e completo della capsula. |
US4983402A (en) | 1989-02-24 | 1991-01-08 | Clinical Technologies Associates, Inc. | Orally administerable ANF |
SE466684B (sv) | 1989-03-07 | 1992-03-23 | Draco Ab | Anordning vid en inhalator samt foerfarande foer att med anordningen registrera medicinering med inhalator |
US5358734A (en) | 1989-03-30 | 1994-10-25 | Gte Products Corporation | Process for producing a blue emitting lamp phosphor |
US5215739A (en) | 1989-04-05 | 1993-06-01 | Toko Yakuhin Kogyo Kabushiki Kaisha | Spray gel base and spray gel preparation using thereof |
US4991605A (en) | 1989-04-24 | 1991-02-12 | Philip Morris Incorporated | Container for additive materials for smoking articles |
US5067500A (en) | 1989-04-24 | 1991-11-26 | Philip Morris Incorporated | Container for additive materials for smoking articles |
EP0470154B1 (en) | 1989-04-28 | 1996-06-05 | Riker Laboratories, Inc. | Dry powder inhalation device |
GB8909891D0 (en) | 1989-04-28 | 1989-06-14 | Riker Laboratories Inc | Device |
US5019400A (en) | 1989-05-01 | 1991-05-28 | Enzytech, Inc. | Very low temperature casting of controlled release microspheres |
DE69005800T2 (de) | 1989-05-01 | 1994-05-19 | Alkermes Inc | Verfahren zur herstellung von kleinen partikeln von biologisch aktiven molekülen. |
US5017383A (en) | 1989-08-22 | 1991-05-21 | Taisho Pharmaceutical Co., Ltd. | Method of producing fine coated pharmaceutical preparation |
GB8919131D0 (en) | 1989-08-23 | 1989-10-04 | Riker Laboratories Inc | Inhaler |
US5270305A (en) | 1989-09-08 | 1993-12-14 | Glaxo Group Limited | Medicaments |
GB8921222D0 (en) | 1989-09-20 | 1989-11-08 | Riker Laboratories Inc | Medicinal aerosol formulations |
DK544589D0 (da) | 1989-11-01 | 1989-11-01 | Novo Nordisk As | Manuel betjent apparat til dispensering af en forudbestemt maengde af et pulverformet stof |
CA2071867A1 (en) | 1989-11-06 | 1991-05-07 | Edith Mathiowitz | Method for producing protein microspheres |
US5188837A (en) | 1989-11-13 | 1993-02-23 | Nova Pharmaceutical Corporation | Lipsopheres for controlled delivery of substances |
US5105291A (en) | 1989-11-20 | 1992-04-14 | Ricoh Company, Ltd. | Liquid crystal display cell with electrodes of substantially amorphous metal oxide having low resistivity |
AU6774790A (en) | 1989-12-06 | 1991-06-13 | Canon Kabushiki Kaisha | Package for ink jet cartridge |
USD331106S (en) | 1989-12-30 | 1992-11-17 | Ing. Erich Pfeiffer Gmbh & Co. Kg | Single use inhaler |
GB9001635D0 (en) | 1990-01-24 | 1990-03-21 | Ganderton David | Aerosol carriers |
US5545618A (en) | 1990-01-24 | 1996-08-13 | Buckley; Douglas I. | GLP-1 analogs useful for diabetes treatment |
US5201308A (en) | 1990-02-14 | 1993-04-13 | Newhouse Michael T | Powder inhaler |
SK280968B6 (sk) | 1990-03-02 | 2000-10-09 | Glaxo Group Limited | Balenie medikamentu na použite v inhalačnom prístroji |
MY105368A (en) | 1990-03-02 | 1994-09-30 | Glaxo Group Ltd | Inhalation device. |
US6536427B2 (en) | 1990-03-02 | 2003-03-25 | Glaxo Group Limited | Inhalation device |
US5615670A (en) | 1990-03-07 | 1997-04-01 | Fisons Plc | Powder inhaler with centrifugal force used to meter powder |
IT1240750B (it) | 1990-04-12 | 1993-12-17 | Chiesi Farma Spa | Dispositivo per la somministrazione di sostanze medicamentose in polvere |
JPH05963A (ja) | 1990-04-13 | 1993-01-08 | Toray Ind Inc | ポリペプチド類組成物 |
US5328464A (en) | 1990-04-24 | 1994-07-12 | Science Incorporated | Closed drug delivery system |
USD338268S (en) | 1990-05-04 | 1993-08-10 | Omron Corporation | Heating inhaler |
AU7908791A (en) | 1990-05-08 | 1991-11-27 | Liposome Technology, Inc. | Direct spray-dried drug/lipid powder composition |
IL111254A (en) | 1990-06-14 | 1998-10-30 | Rhone Poulenc Rorer Ltd | Powder inhalers |
DE4021263C2 (de) | 1990-07-04 | 1996-04-11 | Pfeiffer Erich Gmbh & Co Kg | Austragvorrichtung für Medien |
GB9015522D0 (en) | 1990-07-13 | 1990-08-29 | Braithwaite Philip W | Inhaler |
US5451410A (en) | 1993-04-22 | 1995-09-19 | Emisphere Technologies, Inc. | Modified amino acids for encapsulating active agents |
US6331318B1 (en) | 1994-09-30 | 2001-12-18 | Emisphere Technologies Inc. | Carbon-substituted diketopiperazine delivery systems |
US5541155A (en) | 1994-04-22 | 1996-07-30 | Emisphere Technologies, Inc. | Acids and acid salts and their use in delivery systems |
US5714167A (en) | 1992-06-15 | 1998-02-03 | Emisphere Technologies, Inc. | Active agent transport systems |
US5629020A (en) | 1994-04-22 | 1997-05-13 | Emisphere Technologies, Inc. | Modified amino acids for drug delivery |
US5443841A (en) | 1992-06-15 | 1995-08-22 | Emisphere Technologies, Inc. | Proteinoid microspheres and methods for preparation and use thereof |
US5447728A (en) | 1992-06-15 | 1995-09-05 | Emisphere Technologies, Inc. | Desferrioxamine oral delivery system |
US5693338A (en) | 1994-09-29 | 1997-12-02 | Emisphere Technologies, Inc. | Diketopiperazine-based delivery systems |
US5578323A (en) | 1992-06-15 | 1996-11-26 | Emisphere Technologies, Inc. | Proteinoid carriers and methods for preparation and use thereof |
JPH04103585A (ja) | 1990-08-24 | 1992-04-06 | Nisshin Flour Milling Co Ltd | ピロリジン環を有する化合物 |
US5074418A (en) | 1990-09-12 | 1991-12-24 | Pitney Bowes Inc. | Ink replenishing system transport and storage container |
SE9002895D0 (sv) | 1990-09-12 | 1990-09-12 | Astra Ab | Inhalation devices for dispensing powders i |
DE69132850T2 (de) | 1990-09-26 | 2002-05-29 | Pharmachemie Bv | Wirbelkammer-Pulverinhalator |
US5170801A (en) | 1990-10-02 | 1992-12-15 | Glaxo Inc. | Medical capsule device actuated by radio-frequency (rf) signal |
FR2667509B1 (fr) | 1990-10-04 | 1995-08-25 | Valois | Inhalateur a poudre, dispositif de conditionnement de microdoses de poudre sous forme de bandes adaptees a etre utilisees dans un inhalateur a poudre, et procede de fabrication de ces bandes. |
IL99699A (en) | 1990-10-10 | 2002-04-21 | Autoimmune Inc | Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes |
GB9024760D0 (en) | 1990-11-14 | 1991-01-02 | Riker Laboratories Inc | Inhalation device and medicament carrier |
US5124291A (en) | 1990-11-15 | 1992-06-23 | The Standard Oil Company | Method for deagglomerating and re-exposing catalyst in a fluid bed reactor |
GB9026191D0 (en) | 1990-12-01 | 1991-01-16 | Harris Pharma Ltd | Breath actuated dispensing device |
GB9027234D0 (en) | 1990-12-15 | 1991-02-06 | Harris Pharma Ltd | An inhalation device |
EP0563120B1 (en) | 1990-12-17 | 1997-10-01 | Minnesota Mining And Manufacturing Company | Inhaler |
US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
GB2253200A (en) | 1991-02-01 | 1992-09-02 | Harris Pharma Ltd | Inhalation apparatus and fracturable capsule for use therewith |
AU1442592A (en) | 1991-02-20 | 1992-09-15 | Nova Pharmaceutical Corporation | Controlled release microparticulate delivery system for proteins |
US5208998A (en) | 1991-02-25 | 1993-05-11 | Oyler Jr James R | Liquid substances freeze-drying systems and methods |
US5469750A (en) | 1991-03-05 | 1995-11-28 | Aradigm Corporation | Method and apparatus for sensing flow in two directions and automatic calibration thereof |
US5404871A (en) | 1991-03-05 | 1995-04-11 | Aradigm | Delivery of aerosol medications for inspiration |
ES2179068T3 (es) | 1991-03-05 | 2003-01-16 | Aradigm Corp | Metodo y dispositivo para corregir el desplazamiento de deriva de un detector de presion de flujo. |
USD338062S (en) | 1991-03-06 | 1993-08-03 | Innovata Biomed Limited | Inhaler |
USD347057S (en) | 1991-03-14 | 1994-05-17 | Technosystem Limited | Inhaler |
US5797391A (en) | 1991-03-28 | 1998-08-25 | Rhone-Poulenc Rorer Limited | Inhaler |
US5413804A (en) | 1991-04-23 | 1995-05-09 | Cacique, Inc. | Process for making whey-derived fat substitute product and products thereof |
US5244653A (en) | 1991-05-01 | 1993-09-14 | Isp Chemicals Inc. | Glycine anhydride dimethylol as a biocide and preservative |
US5327883A (en) | 1991-05-20 | 1994-07-12 | Dura Pharmaceuticals, Inc. | Apparatus for aerosolizing powdered medicine and process and using |
US6055980A (en) | 1991-05-20 | 2000-05-02 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
US6060069A (en) | 1991-05-20 | 2000-05-09 | Dura Pharmaceuticals, Inc. | Pulmonary delivery of pharmaceuticals |
US5492112A (en) | 1991-05-20 | 1996-02-20 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
FR2676929B1 (fr) | 1991-05-30 | 1994-02-11 | Aerosols Bouchage Ste Fse | Inhalateur de poudres. |
AU653026B2 (en) | 1991-06-07 | 1994-09-15 | Teikoku Seiyaku Kabushiki Kaisha | Physiologically active polypeptide-containing pharmaceutical composition |
IT1248059B (it) | 1991-06-14 | 1995-01-05 | Miat Spa | Insufflatore multidose per farmaci in polvere |
ATE189124T1 (de) | 1991-07-02 | 2000-02-15 | Inhale Inc | Verfahren und vorrichtung zum abgeben von medikamenten in aerosolform |
US6681767B1 (en) | 1991-07-02 | 2004-01-27 | Nektar Therapeutics | Method and device for delivering aerosolized medicaments |
US5203768A (en) | 1991-07-24 | 1993-04-20 | Alza Corporation | Transdermal delivery device |
US5337740A (en) | 1991-08-01 | 1994-08-16 | New England Pharmaceuticals, Inc. | Inhalation devices |
GB9116610D0 (en) | 1991-08-01 | 1991-09-18 | Danbiosyst Uk | Preparation of microparticles |
US5139878A (en) | 1991-08-12 | 1992-08-18 | Allied-Signal Inc. | Multilayer film constructions |
EP0528764B1 (en) | 1991-08-16 | 1996-06-12 | Sandoz Ltd. | Inhaler for administration of powdery substances |
US5287850A (en) | 1991-08-20 | 1994-02-22 | Habley Medical Technology Corporation | Timing and velocity controlled powered pharmaceutical inhaler |
US6029661A (en) | 1991-08-26 | 2000-02-29 | 3M Innovative Properties Company | Powder dispenser |
USD337636S (en) | 1991-09-12 | 1993-07-20 | Devilbiss Health Care, Inc. | Ultrasonic medicament nebulizer |
US5167506A (en) | 1991-10-24 | 1992-12-01 | Minnesota Mining And Manufacturing Company | Inhalation device training system |
USD348100S (en) | 1991-10-29 | 1994-06-21 | Fisons Plc | Medicament inhaler |
USD350602S (en) | 1991-11-01 | 1994-09-13 | Rhone-Poulenc Rorer Limited | Combined dry powder inhaler and cap |
US6063910A (en) | 1991-11-14 | 2000-05-16 | The Trustees Of Princeton University | Preparation of protein microparticles by supercritical fluid precipitation |
USD350821S (en) | 1991-11-18 | 1994-09-20 | Smithkline Beecham P.L.C. | Oral inhaler |
SE9103572D0 (sv) | 1991-11-29 | 1991-11-29 | Astra Ab | Organic salts of n,n'-diacetyl cystine |
USD340975S (en) | 1991-12-02 | 1993-11-02 | Thayer Medical Corporation | Combined expansion chamber metered dose inhaler dispenser and adaptor |
US5338837A (en) | 1991-12-13 | 1994-08-16 | The Trustees Of Princeton University | Glycosylated steroid derivatives for transport across biological membranes and process for making same |
DE4211475A1 (de) | 1991-12-14 | 1993-06-17 | Asta Medica Ag | Pulverinhalator |
JP3121080B2 (ja) | 1991-12-19 | 2000-12-25 | アール・ピー・シーラー コーポレイション | カプセル封入用溶液 |
GB2262452B (en) | 1991-12-19 | 1995-12-20 | Minnesota Mining & Mfg | Inhalation device |
US5363842A (en) | 1991-12-20 | 1994-11-15 | Circadian, Inc. | Intelligent inhaler providing feedback to both patient and medical professional |
US5525519A (en) | 1992-01-07 | 1996-06-11 | Middlesex Sciences, Inc. | Method for isolating biomolecules from a biological sample with linear polymers |
US5320094A (en) | 1992-01-10 | 1994-06-14 | The Johns Hopkins University | Method of administering insulin |
WO1993013752A1 (en) | 1992-01-21 | 1993-07-22 | Sri International | Improved process for preparing micronized polypeptide drugs |
DE9209050U1 (de) | 1992-02-13 | 1992-10-01 | Schrader, Barthold von, 2400 Travemünde | Inhalationseinrichtung |
US5476093A (en) | 1992-02-14 | 1995-12-19 | Huhtamaki Oy | Device for more effective pulverization of a powdered inhalation medicament |
US5469971A (en) | 1992-02-26 | 1995-11-28 | Estee Lauder Inc. | Method and apparatus for deagglomerating powder |
EP0558879B1 (en) | 1992-03-04 | 1997-05-14 | Astra Aktiebolag | Disposable inhaler |
US5639441A (en) | 1992-03-06 | 1997-06-17 | Board Of Regents Of University Of Colorado | Methods for fine particle formation |
US5352461A (en) | 1992-03-11 | 1994-10-04 | Pharmaceutical Discovery Corporation | Self assembling diketopiperazine drug delivery system |
DK36392D0 (da) | 1992-03-19 | 1992-03-19 | Novo Nordisk As | Anvendelse af kemisk forbindelse |
USD348929S (en) | 1992-04-03 | 1994-07-19 | Norton Healthcare Limited | Medicament inhaler |
CA2096302A1 (en) | 1992-05-15 | 1993-11-16 | David Kilis | Air flow controller and recording system |
USD344796S (en) | 1992-06-11 | 1994-03-01 | Schering Corporation | Combined inhaler and cover |
USD350193S (en) | 1992-06-11 | 1994-08-30 | Schering Corporation | Combined inhaler and cover |
USD344797S (en) | 1992-06-11 | 1994-03-01 | Schering Corporation | Combined inhaler and cover |
USD345013S (en) | 1992-06-11 | 1994-03-08 | Schering Corporation | Combined inhaler and cover |
DE69330672T2 (de) | 1992-06-12 | 2002-06-27 | Teijin Ltd | Pharmazeutische zubereitung zur anwendung in den atemwegen |
US5811127A (en) | 1992-06-15 | 1998-09-22 | Emisphere Technologies, Inc. | Desferrioxamine oral delivery system |
US5792451A (en) | 1994-03-02 | 1998-08-11 | Emisphere Technologies, Inc. | Oral drug delivery compositions and methods |
US5394868A (en) | 1992-06-25 | 1995-03-07 | Schering Corporation | Inhalation device for powdered medicaments |
GB9213874D0 (en) | 1992-06-30 | 1992-08-12 | Fisons Plc | Process to novel medicament form |
US5785049A (en) | 1994-09-21 | 1998-07-28 | Inhale Therapeutic Systems | Method and apparatus for dispersion of dry powder medicaments |
US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
US6509006B1 (en) | 1992-07-08 | 2003-01-21 | Inhale Therapeutic Systems, Inc. | Devices compositions and methods for the pulmonary delivery of aerosolized medicaments |
GB9214819D0 (en) | 1992-07-13 | 1992-08-26 | Minnesota Mining & Mfg | Valve assemblies |
GB9216038D0 (en) | 1992-07-28 | 1992-09-09 | Bespak Plc | Dispensing apparatus for powdered medicaments |
GB2269992A (en) | 1992-08-14 | 1994-03-02 | Rh Ne Poulenc Rorer Limited | Powder inhalation formulations |
GB2270293A (en) | 1992-09-05 | 1994-03-09 | Medix Ltd | Drug dispensing system |
USD348928S (en) | 1992-09-21 | 1994-07-19 | Schering Corporation | Inhaler |
US5333106A (en) | 1992-10-09 | 1994-07-26 | Circadian, Inc. | Apparatus and visual display method for training in the power use of aerosol pharmaceutical inhalers |
WO1994008599A1 (en) | 1992-10-14 | 1994-04-28 | The Regents Of The University Of Colorado | Ion-pairing of drugs for improved efficacy and delivery |
DK0665759T3 (da) | 1992-10-19 | 1999-08-23 | Dura Pharma Inc | Tørpulverinhalator |
AU121578S (en) | 1992-10-22 | 1994-09-20 | Fisons Plc | An inhalation device |
USD359555S (en) | 1992-11-18 | 1995-06-20 | Nippon Glaxo Limited | Nasal medicine inhaler |
USD352107S (en) | 1992-12-10 | 1994-11-01 | Ciba-Geigy Corporation | Inhaler |
USD349572S (en) | 1992-12-10 | 1994-08-09 | Schering Corporation | Aerosol inhaler |
SE9203743D0 (sv) | 1992-12-11 | 1992-12-11 | Astra Ab | Efficient use |
US6250300B1 (en) | 1992-12-11 | 2001-06-26 | Ab Astra | System for dispensing pharmaceutically active compounds |
JP2924924B2 (ja) | 1992-12-18 | 1999-07-26 | シェリング・コーポレーション | 粉末薬物のための吸入器 |
US5401516A (en) | 1992-12-21 | 1995-03-28 | Emisphere Technologies, Inc. | Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof |
US6105571A (en) | 1992-12-22 | 2000-08-22 | Electrosols, Ltd. | Dispensing device |
US6880554B1 (en) | 1992-12-22 | 2005-04-19 | Battelle Memorial Institute | Dispensing device |
US5896855A (en) | 1992-12-24 | 1999-04-27 | Rhone-Poulenc Rorer Limited | Multi dose inhaler apparatus |
FR2700279B1 (fr) | 1993-01-14 | 1995-03-17 | Valois | Dispositif portatif pour projeter des doses d'une substance fluide à l'aide d'un flux d'air comprimé. |
AU119600S (en) | 1993-01-21 | 1994-03-07 | Boehringer Ingelheim Kg | Inhaler device |
US5364838A (en) | 1993-01-29 | 1994-11-15 | Miris Medical Corporation | Method of administration of insulin |
US6131567A (en) | 1993-01-29 | 2000-10-17 | Aradigm Corporation | Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
US5672581A (en) * | 1993-01-29 | 1997-09-30 | Aradigm Corporation | Method of administration of insulin |
US5888477A (en) | 1993-01-29 | 1999-03-30 | Aradigm Corporation | Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin |
US6024090A (en) | 1993-01-29 | 2000-02-15 | Aradigm Corporation | Method of treating a diabetic patient by aerosolized administration of insulin lispro |
US7448375B2 (en) | 1993-01-29 | 2008-11-11 | Aradigm Corporation | Method of treating diabetes mellitus in a patient |
US5441060A (en) | 1993-02-08 | 1995-08-15 | Duke University | Dry powder delivery system |
IL108780A (en) | 1993-02-27 | 1999-06-20 | Fisons Plc | inhaler |
DE69413528T2 (de) | 1993-04-06 | 1999-05-06 | Minnesota Mining & Mfg | Vorrichtung zum deagglomerieren für trockenpulverinhalatoren |
US5372128A (en) | 1993-04-14 | 1994-12-13 | Habley Medical Technology Corporation | Fluidizing powder inhaler |
JP4361601B2 (ja) | 1993-04-22 | 2009-11-11 | エミスフェアー・テクノロジーズ・インク | 経口薬剤移送組成物およびその方法 |
ZA939608B (en) | 1993-04-22 | 1994-08-24 | Emisphere Tech Inc | Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof. |
US5643957A (en) | 1993-04-22 | 1997-07-01 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5360614A (en) | 1993-04-26 | 1994-11-01 | The Estee Corporation | Method of controlling the release of carbohydrates by encapsulation and composition therefor |
NZ265956A (en) | 1993-04-28 | 1996-09-25 | Akzo Nobel Nv | Lyospheres containing gonadotropin and compositions thereof |
DE69416245T2 (de) | 1993-05-12 | 1999-07-08 | Teijin Ltd | Vorrichtung und verfahren zur dosierten abgabe von pulverförmigen arzneistoffen |
US5424286A (en) | 1993-05-24 | 1995-06-13 | Eng; John | Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same |
US5533502A (en) | 1993-05-28 | 1996-07-09 | Vortran Medical Technology, Inc. | Powder inhaler with aerosolization occurring within each individual powder receptacle |
USD365876S (en) | 1993-06-16 | 1996-01-02 | Chawla Brindra P S | Medicament inhaler |
TW402506B (en) | 1993-06-24 | 2000-08-21 | Astra Ab | Therapeutic preparation for inhalation |
IS1796B (is) | 1993-06-24 | 2001-12-31 | Ab Astra | Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband |
US6632456B1 (en) | 1993-06-24 | 2003-10-14 | Astrazeneca Ab | Compositions for inhalation |
US5506203C1 (en) | 1993-06-24 | 2001-02-06 | Astra Ab | Systemic administration of a therapeutic preparation |
US5747445A (en) * | 1993-06-24 | 1998-05-05 | Astra Aktiebolag | Therapeutic preparation for inhalation |
US5562909A (en) | 1993-07-12 | 1996-10-08 | Massachusetts Institute Of Technology | Phosphazene polyelectrolytes as immunoadjuvants |
GB9314614D0 (en) | 1993-07-14 | 1993-08-25 | Minnesota Mining & Mfg | Dry powder inhalers |
US5371046A (en) | 1993-07-22 | 1994-12-06 | Taiwan Semiconductor Manufacturing Company | Method to solve sog non-uniformity in the VLSI process |
JPH0741428A (ja) | 1993-07-30 | 1995-02-10 | Teijin Ltd | ペプチド、蛋白質性薬物経鼻・経肺製剤 |
US5306453A (en) | 1993-08-18 | 1994-04-26 | Edward Shulman | Apparatus and method of making a non-woven fabric |
DE69413989T2 (de) | 1993-08-18 | 1999-04-08 | Fisons Plc | Inhalator mit atemstromregelung |
US5524613A (en) | 1993-08-25 | 1996-06-11 | Habley Medical Technology Corporation | Controlled multi-pharmaceutical inhaler |
BE1007551A3 (nl) | 1993-09-24 | 1995-08-01 | Philips Electronics Nv | Werkwijze voor het in een rekenmachine automatisch herstellen van consistentie in een hierarchische objektstruktuur na een interaktie door een gebruiker en rekenmachine voorzien van zo een systeem voor automatische consistentieherstelling. |
US5477285A (en) | 1993-10-06 | 1995-12-19 | Thomson Consumer Electronics, Inc. | CRT developing apparatus |
GB9322014D0 (en) | 1993-10-26 | 1993-12-15 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
US5726156A (en) | 1995-03-06 | 1998-03-10 | Trega Biosciences, Inc. | Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
NZ276305A (en) | 1993-11-16 | 1997-10-24 | Depotech Corp | Controlled release vesicle compositions |
EP0655237A1 (de) | 1993-11-27 | 1995-05-31 | Hoechst Aktiengesellschaft | Medizinische Aerosolformulierung |
USD358880S (en) | 1993-12-02 | 1995-05-30 | Tenax Corporation | Dry powder inhalator |
US5705483A (en) | 1993-12-09 | 1998-01-06 | Eli Lilly And Company | Glucagon-like insulinotropic peptides, compositions and methods |
DE4422710C1 (de) | 1994-06-29 | 1995-09-14 | Boehringer Ingelheim Kg | Inhalationsgerät mit einem Elektronikmodul zur Funktionsüberwachung |
CN1133470C (zh) | 1993-12-18 | 2004-01-07 | 默克专利股份有限公司 | 粉末吸入器 |
USD357603S (en) | 1993-12-20 | 1995-04-25 | Wolff Stephen H | Base for displaying or holding items |
US5415162A (en) | 1994-01-18 | 1995-05-16 | Glaxo Inc. | Multi-dose dry powder inhalation device |
US5484606A (en) | 1994-01-24 | 1996-01-16 | The Procter & Gamble Company | Process for reducing the precipitation of difficulty soluble pharmaceutical actives |
PT101450B (pt) | 1994-02-02 | 1999-11-30 | Hovione Produtos Farmaceuticos | Novo dispositivo para inalacao |
CA2182988A1 (en) | 1994-02-09 | 1995-08-17 | Kinerton Limited | Process for drying a material from solution |
SE9400462D0 (sv) | 1994-02-11 | 1994-02-11 | Astra Ab | Filling device |
US6051256A (en) | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
ATE264096T1 (de) | 1994-03-07 | 2004-04-15 | Nektar Therapeutics | Verfahren und mittel zur verabreichung von insulin über die lunge |
US5505194A (en) | 1994-03-23 | 1996-04-09 | Abbott Laboratories | Aerosol inhalation device having slideably and rotatably connected elliptical cylinder portions |
AU124387S (en) | 1994-03-25 | 1995-08-11 | Astra Ab | Training device for an inhaler |
US5839429A (en) | 1994-03-25 | 1998-11-24 | Astra Aktiebolag | Method and apparatus in connection with an inhaler |
ATE156677T1 (de) | 1994-04-15 | 1997-08-15 | Fissler Gmbh | Gar- und/oder kochgerät, welches für eine bodenseitige zuführung von wärmeenergie durch wärmeleitung oder durch elektromagnetische induktion eingerichtet ist |
US6395744B1 (en) | 1994-04-22 | 2002-05-28 | Queen's University At Kingston | Method and compositions for the treatment or amelioration of female sexual dysfunction |
FI942196A (fi) | 1994-05-11 | 1995-11-12 | Orion Yhtymae Oy | Jauheinhalaattori |
AU696387B2 (en) | 1994-05-18 | 1998-09-10 | Inhale Therapeutic Systems, Inc. | Methods and compositions for the dry powder formulation of interferons |
AU2517095A (en) | 1994-05-19 | 1995-12-18 | R.P. Scherer International Corporation | Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions |
US5483954A (en) | 1994-06-10 | 1996-01-16 | Mecikalski; Mark B. | Inhaler and medicated package |
IL110024A (en) | 1994-06-15 | 1998-04-05 | Yissum Res Dev Co | Controlled release oral drug delivery system containing hydrogel- forming polymer |
USD363775S (en) | 1994-06-21 | 1995-10-31 | Rhone-Poulenc Rorer Limited | Multidose dry powder inhaler |
USD362500S (en) | 1994-06-28 | 1995-09-19 | Thayer Medical Corporation | Medication inhaler spacer |
US5641510A (en) | 1994-07-01 | 1997-06-24 | Genentech, Inc. | Method for treating capsules used for drug storage |
US6039208A (en) | 1994-07-29 | 2000-03-21 | Ortho Pharmaceutical Corporation | Variable day start tablet dispenser |
US5562231A (en) | 1994-07-29 | 1996-10-08 | Ortho Pharmaceutical Corporation | Variable day start tablet dispenser |
US5623724A (en) | 1994-08-09 | 1997-04-22 | Northrop Grumman Corporation | High power capacitor |
GB9416884D0 (en) | 1994-08-20 | 1994-10-12 | Danbiosyst Uk | Drug delivery compositions |
USD359153S (en) | 1994-08-25 | 1995-06-13 | Viggiano Bernard J | Muffin top |
US5574008A (en) | 1994-08-30 | 1996-11-12 | Eli Lilly And Company | Biologically active fragments of glucagon-like insulinotropic peptide |
US5547929A (en) | 1994-09-12 | 1996-08-20 | Eli Lilly And Company | Insulin analog formulations |
NZ293163A (en) | 1994-09-21 | 1998-09-24 | Inhale Therapeutic Syst | Inhalation medicament disperser, aerosol from high pressure gas entrainment of fluidised powder drawn from receptacle feed tube |
FR2725626A1 (fr) | 1994-10-18 | 1996-04-19 | Sofab | Dispositif pour l'inhalation de produits en poudre |
AU4010395A (en) | 1994-10-27 | 1996-05-23 | Amgen, Inc. | Compositions for increased bioavailability of orally delivered therapeutic agents |
SE9404140D0 (sv) | 1994-11-29 | 1994-11-29 | Astra Ab | Dose indicating device |
EP0805149A4 (en) | 1994-12-01 | 1998-03-11 | Toyama Chemical Co Ltd | NEW 2,3-DICETOPIPERAZINE DERIVATIVE OR SALT THEREOF |
SE9404439D0 (sv) | 1994-12-21 | 1994-12-21 | Astra Ab | Inhalation device |
AR002009A1 (es) | 1994-12-22 | 1998-01-07 | Astra Ab | Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco. |
US6485726B1 (en) | 1995-01-17 | 2002-11-26 | The Brigham And Women's Hospital, Inc. | Receptor specific transepithelial transport of therapeutics |
KR100390480B1 (ko) | 1995-01-23 | 2003-10-04 | 디렉트-할러 아/에스 | 흡입기 |
USD368364S (en) | 1995-02-02 | 1996-04-02 | Reitano Joseph R | Inhaler case |
US5901703A (en) | 1995-02-06 | 1999-05-11 | Unisia Jecs Corporation | Medicine administering device for nasal cavities |
US5660835A (en) | 1995-02-24 | 1997-08-26 | East Carolina University | Method of treating adenosine depletion |
EP0870699A3 (en) | 1995-03-10 | 1998-10-21 | Minnesota Mining And Manufacturing Company | Aerosol valves |
US5653961A (en) | 1995-03-31 | 1997-08-05 | Minnesota Mining And Manufacturing Company | Butixocort aerosol formulations in hydrofluorocarbon propellant |
US5542539A (en) | 1995-04-04 | 1996-08-06 | Ethicon Endo-Surgery, Inc. | Container for quick release packages for surgical instruments |
USD377215S (en) | 1995-04-13 | 1997-01-07 | Glaxo Group Limited | Inhaler |
US6309671B1 (en) | 1995-04-14 | 2001-10-30 | Inhale Therapeutic Systems | Stable glassy state powder formulations |
US5990077A (en) | 1995-04-14 | 1999-11-23 | 1149336 Ontario Inc. | Glucagon-like peptide-2 and its therapeutic use |
US5645051A (en) | 1995-04-21 | 1997-07-08 | Dura Pharmaceuticals, Inc. | Unit dose dry powder inhaler |
US5622166A (en) | 1995-04-24 | 1997-04-22 | Dura Pharmaceuticals, Inc. | Dry powder inhaler delivery system |
US5921237A (en) | 1995-04-24 | 1999-07-13 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
US6428771B1 (en) | 1995-05-15 | 2002-08-06 | Pharmaceutical Discovery Corporation | Method for drug delivery to the pulmonary system |
US5922253A (en) | 1995-05-18 | 1999-07-13 | Alkermes Controlled Therapeutics, Inc. | Production scale method of forming microparticles |
US5809997A (en) | 1995-05-18 | 1998-09-22 | Medtrac Technologies, Inc. | Electronic medication chronolog device |
US5924419A (en) | 1995-05-22 | 1999-07-20 | Kotliar; Igor K. | Apparatus for passive hypoxic training and therapy |
DE19519840A1 (de) | 1995-05-31 | 1996-12-05 | Kaewert Klaus | Gelantinekapsel |
US5714007A (en) | 1995-06-06 | 1998-02-03 | David Sarnoff Research Center, Inc. | Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate |
AU128811S (en) | 1995-06-06 | 1996-12-03 | Orion Yhtymae Oy | A protective cover for example a moisture protective cover for a powder inhaler |
US5919897A (en) | 1995-06-07 | 1999-07-06 | Torrey Pines Institute For Molecular Studies | MU opioid receptor ligands: agonists and antagonists |
US5641861A (en) | 1995-06-07 | 1997-06-24 | Torrey Pines Institute For Molecular Studies | μopioid receptor ligands: agonists and antagonists |
US5824345A (en) | 1995-06-07 | 1998-10-20 | Emisphere Technologies, Inc. | Fragrances and flavorants |
US5610271A (en) | 1995-06-07 | 1997-03-11 | Torrey Pines Institute For Molecular Studies | Kappa receptor selective opioid peptides |
US6193844B1 (en) | 1995-06-07 | 2001-02-27 | Mclaughlin John R. | Method for making paper using microparticles |
US6672304B1 (en) | 1995-06-08 | 2004-01-06 | Innovative Devices, Llc | Inhalation actuated device for use with metered dose inhalers (MDIs) |
US6357442B1 (en) | 1995-06-08 | 2002-03-19 | Innovative Devices, Llc | Inhalation actuated device for use with metered dose inhalers (MDIS) |
ATE209518T1 (de) | 1995-06-21 | 2001-12-15 | Asta Medica Ag | Arzneipulverkartusche mit integrierter dosiereinrichtung, sowie pulverinhalator |
GB9513218D0 (en) | 1995-06-29 | 1995-09-06 | Fisons Plc | Inhalation device and method |
DE19523516C1 (de) | 1995-06-30 | 1996-10-31 | Asta Medica Ag | Inhalator zum Verabreichen von Medikamenten aus Blisterpackungen |
AU131838S (en) | 1995-07-01 | 1997-10-21 | Glaxo Group Ltd | Inhalation device |
JP3098401B2 (ja) | 1995-07-12 | 2000-10-16 | 株式会社エルティーティー研究所 | 経鼻投与用製剤 |
US5758638A (en) | 1995-07-24 | 1998-06-02 | Kreamer; Jeffry W. | Indicator for a medicament inhaler |
US5642727A (en) | 1995-07-25 | 1997-07-01 | David Sarnoff Research Center, Inc. | Inhaler apparatus using a tribo-electric charging technique |
WO1997004747A1 (en) | 1995-07-27 | 1997-02-13 | Dunn James M | Drug delivery systems for macromolecular drugs |
US6209538B1 (en) | 1995-08-02 | 2001-04-03 | Robert A. Casper | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament |
SE9502799D0 (sv) | 1995-08-10 | 1995-08-10 | Astra Ab | Device in inhalers |
SE9502800D0 (sv) | 1995-08-10 | 1995-08-10 | Astra Ab | Disposable inhaler |
JP3317823B2 (ja) | 1995-08-11 | 2002-08-26 | 株式会社ユニシアジェックス | 投薬器 |
US5746197A (en) | 1995-08-18 | 1998-05-05 | Williams; Jeffery W. | Extension for metered dose inhaler |
US5980865A (en) | 1995-08-18 | 1999-11-09 | Baker Norton Pharmaceuticals, Inc. | Method for treating late phase allergic reactions and inflammatory diseases |
US5690910A (en) | 1995-08-18 | 1997-11-25 | Baker Norton Pharmaceuticals, Inc. | Method for treating asthma |
US6852690B1 (en) | 1995-08-22 | 2005-02-08 | Amylin Pharmaceuticals, Inc. | Method and composition for enhanced parenteral nutrition |
FR2738153B1 (fr) | 1995-09-04 | 1998-01-02 | Valois | Appareil d'inhalation destine a distribuer des doses precises et reproductibles de produit pulverulent |
US5617844A (en) | 1995-09-21 | 1997-04-08 | King; Russell W. | Aerosol medication delivery system |
KR0124764Y1 (ko) | 1995-09-23 | 1998-09-15 | 양주환 | 의약 및 식품용 하드 공 캅셀 |
SE9503344D0 (sv) | 1995-09-27 | 1995-09-27 | Astra Ab | Inhalation device |
US5849322A (en) | 1995-10-23 | 1998-12-15 | Theratech, Inc. | Compositions and methods for buccal delivery of pharmaceutical agents |
US5766620A (en) | 1995-10-23 | 1998-06-16 | Theratech, Inc. | Buccal delivery of glucagon-like insulinotropic peptides |
AU7678196A (en) | 1995-11-13 | 1997-06-05 | Minimed, Inc. | Methods and compositions for the delivery of monomeric proteins |
DE19545257A1 (de) | 1995-11-24 | 1997-06-19 | Schering Ag | Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln |
ATE193455T1 (de) | 1995-12-07 | 2000-06-15 | Jago Pharma Ag | Inhalator zur mehrfachen dosisweisen abgabe eines pharmakologischen trockenpulvers |
US7131441B1 (en) | 1995-12-07 | 2006-11-07 | Skyepharma Ag | Inhaler for multiple dosed administration of a pharmacological dry powder |
WO1997025086A2 (en) | 1996-01-03 | 1997-07-17 | Glaxo Group Limited | Inhalation device |
US6026809A (en) | 1996-01-25 | 2000-02-22 | Microdose Technologies, Inc. | Inhalation device |
US6470884B2 (en) | 1996-01-29 | 2002-10-29 | Aventis Pharma Limited | Capsule opening arrangement for use in a powder inhaler |
JPH09208485A (ja) | 1996-01-31 | 1997-08-12 | Teijin Ltd | ペプチド・蛋白質性薬物の水難溶性組成物 |
KR19990082348A (ko) | 1996-02-06 | 1999-11-25 | 이.아이,듀우판드네모아앤드캄파니 | 플라즈마 활성화 종을 갖는 탈집괴 입자의 처리 |
USD381416S (en) | 1996-02-08 | 1997-07-22 | Astra Aktiebolag | Unit dose inhaler |
HU221033B1 (hu) | 1996-02-21 | 2002-07-29 | Schering Corp. | Poradagoló készülék |
USD377861S (en) | 1996-02-21 | 1997-02-11 | Medport, Inc. | Inhaler carrying case |
DK0943326T4 (da) | 1996-02-27 | 2007-01-22 | Teijin Ltd | Pulveragtigt præparat til nasal administration |
US6509313B1 (en) | 1996-02-28 | 2003-01-21 | Cornell Research Foundation, Inc. | Stimulation of immune response with low doses of cytokines |
US5699789A (en) | 1996-03-11 | 1997-12-23 | Hendricks; Mark R. | Dry powder inhaler |
JP3328132B2 (ja) | 1996-03-21 | 2002-09-24 | 株式会社ユニシアジェックス | 吸入式投薬器 |
GB9606188D0 (en) | 1996-03-23 | 1996-05-29 | Danbiosyst Uk | Pollysaccharide microspheres for the pulmonary delivery of drugs |
USD395499S (en) | 1996-04-08 | 1998-06-23 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
US5875776A (en) | 1996-04-09 | 1999-03-02 | Vivorx Pharmaceuticals, Inc. | Dry powder inhaler |
US5858099A (en) | 1996-04-09 | 1999-01-12 | Sarnoff Corporation | Electrostatic chucks and a particle deposition apparatus therefor |
DE69724420T2 (de) | 1996-04-29 | 2004-06-09 | Quadrant Technologies Ltd. | Verfahren zum inhalieren trockener pulver |
US5817343A (en) | 1996-05-14 | 1998-10-06 | Alkermes, Inc. | Method for fabricating polymer-based controlled-release devices |
AU132977S (en) | 1996-05-17 | 1998-02-17 | Astrazeneca Ab | Container for inhaling apparatus |
US5985309A (en) | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
US6503480B1 (en) | 1997-05-23 | 2003-01-07 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
US6254854B1 (en) | 1996-05-24 | 2001-07-03 | The Penn Research Foundation | Porous particles for deep lung delivery |
USRE37053E1 (en) | 1996-05-24 | 2001-02-13 | Massachusetts Institute Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
AU3376297A (en) | 1996-06-05 | 1998-01-05 | Sandra Mclachlan | Human thyrotropin receptor compositions and use thereof |
US5871010A (en) | 1996-06-10 | 1999-02-16 | Sarnoff Corporation | Inhaler apparatus with modified surfaces for enhanced release of dry powders |
AUPO066096A0 (en) | 1996-06-26 | 1996-07-18 | Peptide Delivery Systems Pty Ltd | Oral delivery of peptides |
US5769276A (en) | 1996-07-10 | 1998-06-23 | Terronics Development Corporation | Powder atomizer |
US5783556A (en) | 1996-08-13 | 1998-07-21 | Genentech, Inc. | Formulated insulin-containing composition |
AU133903S (en) | 1996-08-19 | 1998-05-29 | Orion Yhtymae Oy | Inhaler device |
US6277819B1 (en) | 1996-08-30 | 2001-08-21 | Eli Lilly And Company | Use of GLP-1 or analogs in treatment of myocardial infarction |
US6006753A (en) | 1996-08-30 | 1999-12-28 | Eli Lilly And Company | Use of GLP-1 or analogs to abolish catabolic changes after surgery |
JP3890099B2 (ja) | 1996-09-30 | 2007-03-07 | キヤノン株式会社 | パターン認識装置及びその方法、及びそのプログラムを記憶した記憶媒体 |
JP3020141B2 (ja) | 1996-10-07 | 2000-03-15 | 株式会社富士薬品 | 経鼻投与用製剤 |
US6532437B1 (en) | 1996-10-23 | 2003-03-11 | Cornell Research Foundation, Inc. | Crystalline frap complex |
UA65549C2 (uk) | 1996-11-05 | 2004-04-15 | Елі Ліллі Енд Компані | Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція |
US6441172B1 (en) | 1996-11-07 | 2002-08-27 | Torrey Pines Institute For Molecular Studies | Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof |
AU4863797A (en) | 1996-11-12 | 1998-06-03 | Novo Nordisk A/S | Use of glp-1 peptides |
DE19647947A1 (de) | 1996-11-20 | 1998-05-28 | Pfeiffer Erich Gmbh & Co Kg | Austragvorrichtung für Medien |
US5868774A (en) | 1996-11-21 | 1999-02-09 | Reil; Vladimir | Unique cartridge and earring stud gun system |
US6159360A (en) | 1996-11-22 | 2000-12-12 | Heinkel Industriezentrifugen Gmbh & Co. | Invertible filter centrifuge including a solids drier |
EP0948410B1 (en) | 1996-12-11 | 2002-04-03 | Earth Sciences Limited | Methods and apparatus for use in processing and treating particulate material |
USD390651S (en) | 1996-12-12 | 1998-02-10 | Inhale Therapeutics Systems | Medicament inhaler housing |
GB9626263D0 (en) | 1996-12-18 | 1997-02-05 | Innovata Biomed Ltd | Powder inhaler |
GB9626233D0 (en) | 1996-12-18 | 1997-02-05 | Chawla Brinda P S | Medicament packaging and deliveery device |
GB2320489A (en) | 1996-12-20 | 1998-06-24 | Norton Healthcare Ltd | Inhaler dose counter |
EP0952821A4 (en) | 1996-12-31 | 2006-07-26 | Nektar Therapeutics | METHODS FOR DRYING AQUEOUS SUSPENSION OF HYDROPHOBIC DRUGS WITH HYDROPHILIC EXCIPIENTS AND COMPOSITIONS PREPARED THEREFROM |
USD397435S (en) | 1997-01-03 | 1998-08-25 | GGU Gesellschaft fuer Gesundheits-und Umweltforschung mbH | Combined inhaler and cover |
US5794613A (en) | 1997-01-09 | 1998-08-18 | Sepracor, Inc. | Multiple-dose dispenser for dry powder inhalers |
USD389238S (en) | 1997-01-24 | 1998-01-13 | Healthscan Products, Inc. | Inhaler mask |
PT898978E (pt) | 1997-01-30 | 2005-07-29 | Dott Ltd Co | Aplicador de medicamentos por inalacao |
US6884435B1 (en) | 1997-01-30 | 2005-04-26 | Chiron Corporation | Microparticles with adsorbent surfaces, methods of making same, and uses thereof |
SE9700421D0 (sv) | 1997-02-07 | 1997-02-07 | Astra Ab | Single dose inhaler I |
SE9700422D0 (sv) | 1997-02-07 | 1997-02-07 | Astra Ab | Single dose inhaler II |
SE9700423D0 (sv) | 1997-02-07 | 1997-02-07 | Astra Ab | Disposable inhaler |
JP3011898B2 (ja) | 1997-02-20 | 2000-02-21 | フォルテ グロウ メディカル株式会社 | 吸引器 |
DE19708406A1 (de) | 1997-03-03 | 1998-09-10 | Alfred Von Schuckmann | Gerät zur dosierten Ausgabe von Substanzen |
USD390653S (en) | 1997-03-04 | 1998-02-10 | Blasdell Richard J | Inhaler |
TW469832U (en) | 1997-03-14 | 2001-12-21 | Astra Ab | Inhalation device |
SE9700936D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | Inhalation device |
SE9700943D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | Powder inhaler V |
SE9700940D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | Powder inhaler IV |
SE9700948D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | Powder inhaler X |
SE9700935D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | Inhalation device |
SE9700937D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | Powder inhaler I |
SE9700938D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | Powder inhaler II and a method of construction thereof |
US6006747A (en) | 1997-03-20 | 1999-12-28 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
US6043214A (en) | 1997-03-20 | 2000-03-28 | Novo Nordisk A/S | Method for producing powder formulation comprising an insulin |
US5904139A (en) | 1997-03-28 | 1999-05-18 | Hauser; Stephen G. | Breath coordinated inhaler |
JP2002510193A (ja) | 1997-03-31 | 2002-04-02 | イーライ・リリー・アンド・カンパニー | グルカゴン様ペプチド−1類似体 |
JP4037464B2 (ja) | 1997-04-01 | 2008-01-23 | シーマ・ラブス・インコーポレイテッド | ブリスタパッケージ及びパッケージタブレット |
BR9808466A (pt) | 1997-04-02 | 2001-08-07 | Purdue Research Foundation | Método para distribuição oral de proteìnas |
PT101988B (pt) | 1997-04-04 | 2004-02-27 | Hovione Farmaciencia Sa | Sistema de orientacao e posicionamento de um objecto |
US5923175A (en) | 1997-06-03 | 1999-07-13 | The United States Of America As Represented By The Secretary Of The Navy | Apparatus for contactless measurement of the electrical resistance of a conductor |
USD410541S (en) | 1997-06-30 | 1999-06-01 | Novartis Ag | Inhaler |
SE9702796D0 (sv) | 1997-07-25 | 1997-07-25 | Pharmacia & Upjohn Ab | A device at a pharmaceutical container or inhaler |
CA2212430A1 (en) | 1997-08-07 | 1999-02-07 | George Volgyesi | Inhalation device |
GB2327895B (en) | 1997-08-08 | 2001-08-08 | Electrosols Ltd | A dispensing device |
US5855564A (en) | 1997-08-20 | 1999-01-05 | Aradigm Corporation | Aerosol extrusion mechanism |
US5846447A (en) | 1997-08-26 | 1998-12-08 | E. I. Du Pont De Nemours And Company | Process for forming a dispersion of polytetrafluoroethylene |
USD416621S (en) | 1997-09-05 | 1999-11-16 | Pharmacia & Upjohn | Two piece inhaler |
USD417271S (en) | 1997-09-10 | 1999-11-30 | Medic-Aid Limited | Drug delivery device |
WO1999014239A1 (de) | 1997-09-12 | 1999-03-25 | Wolf Georg Forssmann | Zusammensetzung zur therapie von diabetes mellitus und fettsucht |
US5848589A (en) | 1997-09-18 | 1998-12-15 | Welnetz; Robert J. | Altitude mask simulator |
AU135340S (en) | 1997-09-24 | 1998-10-12 | Innovata Biomed Ltd | An inhaler |
US6394085B1 (en) | 1997-09-25 | 2002-05-28 | Norton Healthcare Ltd. | Inhaler spacer |
US6073629A (en) | 1997-09-25 | 2000-06-13 | Norton Healthcare Ltd. | Inhaler spacer |
USD463544S1 (en) | 1997-09-26 | 2002-09-24 | 1263152 Ontario Inc. | Aerosol medication delivery inhaler |
US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
DE69738333T2 (de) | 1997-10-01 | 2008-11-27 | Novadel Pharma Inc. | Nichtpolares Spray zur bukkalen Verabreichung |
US6228394B1 (en) | 1997-10-14 | 2001-05-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | Supercritical fluid extraction of mould lubricant from hard shell capsules |
US5954047A (en) | 1997-10-17 | 1999-09-21 | Systemic Pulmonary Development, Ltd. | Methods and apparatus for delivering aerosolized medication |
USD398992S (en) | 1997-10-21 | 1998-09-29 | Schering-Plough Healthcare Products, Inc. | Nasal inhaler |
ZA989744B (en) | 1997-10-31 | 2000-04-26 | Lilly Co Eli | Method for administering acylated insulin. |
IN188720B (ja) | 1997-11-06 | 2002-11-02 | Panacea Biotec Ltd | |
AU135120S (en) | 1997-11-14 | 1998-09-21 | Astrazeneca Ab | Inhaler |
SE9704184D0 (sv) | 1997-11-14 | 1997-11-14 | Astra Ab | Inhalation device |
US6116238A (en) | 1997-12-02 | 2000-09-12 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
USD412978S (en) | 1997-12-02 | 1999-08-17 | Dura Pharmaceuticals, Inc. | Inhaler |
USD418600S (en) | 1997-12-04 | 2000-01-04 | Charmaine Haerle | Inhaler clip |
JP2001525371A (ja) | 1997-12-05 | 2001-12-11 | イーライ・リリー・アンド・カンパニー | Glp−1製剤 |
US6192876B1 (en) | 1997-12-12 | 2001-02-27 | Astra Aktiebolag | Inhalation apparatus and method |
US6380357B2 (en) | 1997-12-16 | 2002-04-30 | Eli Lilly And Company | Glucagon-like peptide-1 crystals |
US5965701A (en) | 1997-12-23 | 1999-10-12 | Ferring Bv | Kappa receptor opioid peptides |
US6077940A (en) | 1997-12-24 | 2000-06-20 | Genentech, Inc. | Free solution ligand interaction molecular separation method |
US6358058B1 (en) | 1998-01-30 | 2002-03-19 | 1263152 Ontario Inc. | Aerosol dispensing inhaler training device |
JP3530004B2 (ja) | 1998-02-06 | 2004-05-24 | 株式会社日立ユニシアオートモティブ | 吸入式投薬器 |
US6158431A (en) | 1998-02-13 | 2000-12-12 | Tsi Incorporated | Portable systems and methods for delivery of therapeutic material to the pulmonary system |
USD421800S (en) | 1998-02-19 | 2000-03-21 | Pierre Fabre Medicament | Powder and compressed-air inhaler |
USD412979S (en) | 1998-02-27 | 1999-08-17 | Diemolding Corporation | Metered dose inhaler spacer |
US7143764B1 (en) | 1998-03-13 | 2006-12-05 | Astrazeneca Ab | Inhalation device |
CN1292714B (zh) | 1998-03-16 | 2012-08-01 | 诺瓦帝斯公司 | 气溶胶化活性剂的输送 |
US6998387B1 (en) | 1998-03-19 | 2006-02-14 | Amylin Pharmaceuticals, Inc. | Human appetite control by glucagon-like peptide receptor binding compounds |
SE9801078D0 (sv) | 1998-03-27 | 1998-03-27 | Shl Medical Ab | Inhalator |
AU138848S (en) | 1998-03-30 | 1999-11-22 | Astra Ab | Inhaler with cap |
AU138849S (en) | 1998-03-30 | 1999-11-22 | Astra Ab | Inhaler with cap |
AU138847S (en) | 1998-03-30 | 1999-11-22 | Astra Ab | Inhaler with cap |
CA2327670A1 (en) | 1998-04-08 | 1999-10-14 | Darrel Lavern Allen | Pulmonary and nasal delivery of raloxifene |
DE59909854D1 (de) | 1998-04-09 | 2004-08-05 | Celanese Ventures Gmbh | Partikulärer wirkstoffträger für die pulmonale applikation |
FR2777283B1 (fr) | 1998-04-10 | 2000-11-24 | Adir | Nouveaux composes peptidiques analogues du glucagon-peptide- 1 (7-37), leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US6578571B1 (en) | 1998-04-20 | 2003-06-17 | Infamed Ltd. | Drug delivery device and methods therefor |
GB9810126D0 (ja) | 1998-05-13 | 1998-07-08 | Glaxo Group Ltd | |
US6257233B1 (en) | 1998-06-04 | 2001-07-10 | Inhale Therapeutic Systems | Dry powder dispersing apparatus and methods for their use |
SE9802080D0 (sv) | 1998-06-11 | 1998-06-11 | Hellstroem | Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein |
US6152130A (en) | 1998-06-12 | 2000-11-28 | Microdose Technologies, Inc. | Inhalation device with acoustic control |
USD412572S (en) | 1998-06-19 | 1999-08-03 | Gray Gene W | Nasal inhaler adaptor for left and right nostril |
ES2228070T3 (es) | 1998-06-22 | 2005-04-01 | Astrazeneca Ab | Dispositivo para aspirar y vaciar cavidades que contienen polvo. |
EP1094781B1 (en) | 1998-07-07 | 2008-07-02 | Transdermal Technologies Inc. | Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof |
DE19831525A1 (de) | 1998-07-14 | 2000-01-20 | Pfeiffer Erich Gmbh & Co Kg | Spender für Medien |
US6703381B1 (en) | 1998-08-14 | 2004-03-09 | Nobex Corporation | Methods for delivery therapeutic compounds across the blood-brain barrier |
US6087334A (en) | 1998-08-21 | 2000-07-11 | Amylin Pharmaceuticals, Inc. | Anti-diabetic peptides |
ES2263282T3 (es) | 1998-08-26 | 2006-12-01 | Teijin Limited | Composiciones en polvo para administracion nasal. |
CZ2001690A3 (cs) | 1998-08-28 | 2002-04-17 | Eli Lilly And Company | Způsob podávání inzulinotropních peptidů |
US6720407B1 (en) | 1998-08-28 | 2004-04-13 | Eli Lilly And Company | Method for administering insulinotropic peptides |
US20020088458A1 (en) | 1998-09-24 | 2002-07-11 | Astrazeneca Ab | Inhaler |
CN1320055A (zh) | 1998-09-24 | 2001-10-31 | 阿斯特拉曾尼卡有限公司 | 吸入器 |
GB9820937D0 (en) | 1998-09-26 | 1998-11-18 | Glaxo Group Ltd | Inhalation device |
GB9820886D0 (en) | 1998-09-26 | 1998-11-18 | Glaxo Group Ltd | Inhalation device |
US6187291B1 (en) | 1998-09-28 | 2001-02-13 | Robert Weinstein | Method and device for facilitating combined aerosol and oral treatments for diabetes mellitus |
USD411005S (en) | 1998-09-29 | 1999-06-15 | Pharmadesign Inc. | Arthritic aid for metered dose inhaler |
UA73924C2 (en) | 1998-10-09 | 2005-10-17 | Nektar Therapeutics | Device for delivering active agent formulation to lungs of human patient |
US6279511B1 (en) | 1998-10-23 | 2001-08-28 | Instech Laboratories, Inc. | Powered multichannel infusion and monitoring system |
US6263871B1 (en) | 1998-10-29 | 2001-07-24 | Richard I. Brown | Mouthpiece with coupler |
US6235725B1 (en) | 1998-10-30 | 2001-05-22 | Baker Norton Pharmaceuticals, Inc. | Methods and compositions for the prevention of tolerance to medications |
US6261594B1 (en) | 1998-11-25 | 2001-07-17 | The University Of Akron | Chitosan-based nitric oxide donor compositions |
US6540672B1 (en) | 1998-12-09 | 2003-04-01 | Novo Nordisk A/S | Medical system and a method of controlling the system for use by a patient for medical self treatment |
GB9827145D0 (en) | 1998-12-09 | 1999-02-03 | Co Ordinated Drug Dev | Improvements in or relating to powders |
US6375975B1 (en) | 1998-12-21 | 2002-04-23 | Generex Pharmaceuticals Incorporated | Pharmaceutical compositions for buccal and pulmonary application |
US6552024B1 (en) | 1999-01-21 | 2003-04-22 | Lavipharm Laboratories Inc. | Compositions and methods for mucosal delivery |
SE9900215D0 (sv) | 1999-01-26 | 1999-01-26 | Pharmacia & Upjohn Ab | New use |
JP2000217917A (ja) | 1999-01-27 | 2000-08-08 | Unisia Jecs Corp | 吸入式投薬器 |
US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
SI1158958T1 (sl) | 1999-03-05 | 2007-10-31 | Chiesi Farma Spa | Izboljĺ ani praĺ kasti farmacevtski sestavki za inhalacijo |
IT1309592B1 (it) | 1999-03-05 | 2002-01-24 | Chiesi Farma Spa | Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e |
US6632258B1 (en) | 1999-03-16 | 2003-10-14 | The United States Of America As Represented By The United States Department Of Energy | Coal beneficiation by gas agglomeration |
US6803044B1 (en) | 1999-03-24 | 2004-10-12 | Zengen, Inc. | Antimicrobial and anti-inflammatory peptides for use in human immunodeficiency virus |
US6630169B1 (en) | 1999-03-31 | 2003-10-07 | Nektar Therapeutics | Particulate delivery systems and methods of use |
DE60026982T2 (de) | 1999-04-05 | 2006-11-16 | Mannkind Corp., Danbury | Verfahren zur bildung von feinem pulver |
USD441859S1 (en) | 1999-04-06 | 2001-05-08 | Istituto Biochimico Pavese Pharma S.P.A. | Disposable dry-powder inhaler |
AU763786B2 (en) | 1999-05-07 | 2003-07-31 | Imerys Pigments, Inc. | A method of treating an aqueous suspension of kaolin |
US6417920B1 (en) | 1999-05-11 | 2002-07-09 | Shimadzu Corporation | Particle size analyzer based on laser diffraction method |
US6514500B1 (en) | 1999-10-15 | 2003-02-04 | Conjuchem, Inc. | Long lasting synthetic glucagon like peptide {GLP-!} |
GB9911388D0 (en) | 1999-05-18 | 1999-07-14 | Glaxo Group Ltd | Dispenser |
MXPA01011660A (es) | 1999-05-20 | 2004-04-05 | Pharmasol Gmbh | Adyuvante optimizado en estabilidad y biocompatibilidad (sba) para aumentar la respuesta inmune humoral y celular. |
US6395300B1 (en) | 1999-05-27 | 2002-05-28 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
US7919119B2 (en) | 1999-05-27 | 2011-04-05 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
DE69910987T2 (de) | 1999-06-14 | 2004-05-19 | Baxter International Inc., Deerfield | Mikrosphären mit verzögerter Wirkstoffabgabe |
US6644315B2 (en) | 1999-06-18 | 2003-11-11 | Saeed Ziaee | Nasal mask |
SE516826C2 (sv) | 1999-06-18 | 2002-03-05 | Shl Medical Ab | Anordning i en inhalator med organ för aktivering och avaktivering av en kanister som svar på ett luftflöde |
US7169889B1 (en) | 1999-06-19 | 2007-01-30 | Biocon Limited | Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin |
DK1133312T3 (da) | 1999-06-21 | 2008-01-02 | Lilly Co Eli | Synergistisk anvendelse af thiazolidindioner med glucagonlignende peptid-1 og agonister deraf til behandling af ikke-insulinafhængig diabetes |
US6858199B1 (en) | 2000-06-09 | 2005-02-22 | Advanced Inhalation Research, Inc. | High efficient delivery of a large therapeutic mass aerosol |
GB2353222B (en) | 1999-06-23 | 2001-09-19 | Cambridge Consultants | Inhalers |
USD444226S1 (en) | 1999-06-24 | 2001-06-26 | Novo Nordisk A/S | Inhaler |
US6606992B1 (en) | 1999-06-30 | 2003-08-19 | Nektar Therapeutics | Systems and methods for aerosolizing pharmaceutical formulations |
ITMI991582A1 (it) | 1999-07-16 | 2001-01-16 | Chiesi Farma Spa | Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala |
US7305986B1 (en) | 1999-07-23 | 2007-12-11 | Mannkind Corporation | Unit dose capsules for use in a dry powder inhaler |
US7464706B2 (en) | 1999-07-23 | 2008-12-16 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
EP1200149B1 (en) | 1999-07-23 | 2006-09-20 | MannKind Corporation | Dry powder inhaler |
CN1175961C (zh) | 1999-09-17 | 2004-11-17 | 株式会社新王磁材 | 稀土合金的切割方法和切割装置 |
USD438612S1 (en) | 1999-09-27 | 2001-03-06 | G-Intek Co., Ltd. | Snivel inhaler |
WO2001024857A1 (de) | 1999-10-06 | 2001-04-12 | Eckardt, Angela | Atemzugskontrolliertes inhalationsgerät für trockenpulver und verfahren zum gleichmässigen verteilen des trockenpulvers in luft |
HU229310B1 (en) | 1999-10-29 | 2013-10-28 | Nektar Therapeutics | Dry powder compositions having improved dispersivity |
SE9903990D0 (sv) | 1999-11-02 | 1999-11-02 | Shl Medical Ab | Inhalator with aerosolizing unit |
GB9928311D0 (en) | 1999-11-30 | 2000-01-26 | Novartis Ag | Organic compounds |
IT1308581B1 (it) | 1999-12-03 | 2002-01-08 | Medel Italiana Srl | Apparato per nebulizzare un liquido, in particolare per uso medico. |
SE9904706D0 (sv) | 1999-12-21 | 1999-12-21 | Astra Ab | An inhalation device |
AR026914A1 (es) | 1999-12-11 | 2003-03-05 | Glaxo Group Ltd | Distribuidor de medicamento |
US7204250B1 (en) | 1999-12-16 | 2007-04-17 | Compumedics Limited | Bio-mask |
US7022674B2 (en) | 1999-12-16 | 2006-04-04 | Eli Lilly And Company | Polypeptide compositions with improved stability |
DE19961300A1 (de) | 1999-12-18 | 2001-06-21 | Asta Medica Ag | Vorratssystem für Arzneimittel in Pulverform und damit ausgestatteter Inhalator |
AU2729101A (en) | 1999-12-21 | 2001-07-03 | Rxkinetix, Inc. | Particulate drug-containing products and method of manufacture |
US7080642B2 (en) | 1999-12-22 | 2006-07-25 | 3M Innovative Properties Company | Refillable device with counting means |
CZ20022265A3 (cs) | 1999-12-30 | 2004-01-14 | Chiron Corporation | Léčivo pro podávání interleukinu-2 a stabilizovaný lyofilizovaný nebo sprejově sušený farmaceutický prostředek s obsahem interleukinu-2 |
JP2003519664A (ja) | 2000-01-11 | 2003-06-24 | ノボ ノルディスク アクティーゼルスカブ | Glp−1誘導体の経上皮送達 |
WO2001052818A1 (en) | 2000-01-19 | 2001-07-26 | Pharmaceutical Discovery Corporation | Dry powder formulations of antihistamine for nasal administration |
EP1248594B1 (en) | 2000-01-19 | 2005-12-14 | Mannkind Corporation | Multi-spike release formulation for drug delivery |
US6540983B1 (en) | 2000-01-25 | 2003-04-01 | Aeropharm Technology Incorporated | Medical aerosol formulation |
US6540982B1 (en) | 2000-01-25 | 2003-04-01 | Aeropharm Technology Incorporated | Medical aerosol formulation |
JP2003523366A (ja) | 2000-01-27 | 2003-08-05 | イーライ・リリー・アンド・カンパニー | グルカゴン様ペプチド1化合物の可溶化方法 |
US6427688B1 (en) | 2000-02-01 | 2002-08-06 | Dura Pharmaceuticals, Icn. | Dry powder inhaler |
US7171965B2 (en) | 2000-02-01 | 2007-02-06 | Valois S.A.S. | Breath actuated dry powder inhaler and tape dose strip |
USD439325S1 (en) | 2000-02-08 | 2001-03-20 | Baker Norton Pharmaceuticals, Inc. | Cover for a nasal inhaler |
EP1129705A1 (en) | 2000-02-17 | 2001-09-05 | Rijksuniversiteit te Groningen | Powder formulation for inhalation |
GB0004456D0 (en) | 2000-02-26 | 2000-04-19 | Glaxo Group Ltd | Medicament dispenser |
EP1941868A3 (en) | 2000-02-28 | 2011-06-29 | PharmaKodex Limited | Improvements in or relating to the delivery of oral drugs |
USD439656S1 (en) | 2000-03-06 | 2001-03-27 | Astrazeneca Uk Limited | Inhaler |
US6443151B1 (en) | 2000-03-08 | 2002-09-03 | Aradigm Corporation | Fluid velocity-sensitive trigger mechanism |
CA2400349C (en) | 2000-03-10 | 2009-11-10 | University Of North Carolina At Chapel Hill | Dry powder inhaler devices, multi-dose dry powder drug packages, control systems, and associated methods |
US6608038B2 (en) | 2000-03-15 | 2003-08-19 | Novartis Ag | Methods and compositions for treatment of diabetes and related conditions via gene therapy |
GB2360218A (en) | 2000-03-18 | 2001-09-19 | Astrazeneca Uk Ltd | Inhaler |
US6823863B2 (en) | 2000-03-18 | 2004-11-30 | Astrazeneca Ab | Inhaler |
GB2360216A (en) | 2000-03-18 | 2001-09-19 | Astrazeneca Uk Ltd | Inhaler |
GB0006525D0 (en) | 2000-03-18 | 2000-05-10 | Astrazeneca Uk Ltd | Inhaler |
SE0000935D0 (sv) | 2000-03-21 | 2000-03-21 | Astrazeneca Ab | An inhalation device |
USD449684S1 (en) | 2000-03-24 | 2001-10-23 | Astrazeneca Ab | Inhaler |
US6432383B1 (en) | 2000-03-30 | 2002-08-13 | Generex Pharmaceuticals Incorporated | Method for administering insulin |
WO2001074247A2 (en) | 2000-04-03 | 2001-10-11 | Iep Pharmaceutical Devices Inc. | Method for measuring changes in the airways of humans and other mammals |
WO2001076671A2 (en) | 2000-04-11 | 2001-10-18 | Trudell Medical International | Aerosol delivery apparatus with positive expiratory pressure capacity |
DE10019879A1 (de) | 2000-04-20 | 2001-10-25 | Degussa | Verfahren zur Herstellung von 2,5-Diketopiperazinen, neue 2,5-Diketopiperazine und deren Verwendung |
MY136453A (en) | 2000-04-27 | 2008-10-31 | Philip Morris Usa Inc | "improved method and apparatus for generating an aerosol" |
US6468507B1 (en) | 2000-05-01 | 2002-10-22 | Aeropharm Technology, Inc. | Non-aqueous aerosol formulation comprising rosiglitazone maleate, a non-aqueous carrier, and an amino acid stabilizer |
US6447750B1 (en) | 2000-05-01 | 2002-09-10 | Aeropharm Technology Incorporated | Medicinal aerosol formulation |
USD442685S1 (en) | 2000-05-02 | 2001-05-22 | Salter Labs | Medication inhaler spacer |
US20010039442A1 (en) | 2000-05-06 | 2001-11-08 | Sal Gorge | Headache relief device |
US6948494B1 (en) | 2000-05-10 | 2005-09-27 | Innovative Devices, Llc. | Medicament container with same side airflow inlet and outlet and method of use |
US20020000225A1 (en) | 2000-06-02 | 2002-01-03 | Carlos Schuler | Lockout mechanism for aerosol drug delivery devices |
CN1141974C (zh) | 2000-06-07 | 2004-03-17 | 张昊 | 结肠定位释放的口服生物制剂 |
EP1695983B1 (en) | 2000-06-16 | 2009-03-04 | Eli Lilly & Company | Glucagon-like peptide-1 analogs |
RU2181297C2 (ru) | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
GB0015034D0 (en) | 2000-06-21 | 2000-08-09 | Glaxo Group Ltd | Inhalation device |
GB0015043D0 (en) | 2000-06-21 | 2000-08-09 | Glaxo Group Ltd | Medicament dispenser |
US6562807B2 (en) | 2000-06-23 | 2003-05-13 | Novo Nordisk A/S | Glucagon antagonists/inverse agonists |
AR028747A1 (es) | 2000-06-23 | 2003-05-21 | Norton Health Care Ltd | Desaglomerador para inhalador de polvo seco accionado por la respiracion, un inhalador de polvo seco y un metodo de desaglomeracion de polvo seco. |
PE20020163A1 (es) | 2000-06-23 | 2002-03-04 | Norton Healthcare Ltd | Sistema presurizado de receptaculo para inhalador de medicamento |
PE20020066A1 (es) | 2000-06-23 | 2002-02-23 | Norton Healthcare Ltd | Deposito de dosis medidas previamente para inhalador de polvo seco accionado por la respiracion |
USD450117S1 (en) | 2000-06-29 | 2001-11-06 | Innovata Biomed Limited | Inhaler |
USD452910S1 (en) | 2000-06-29 | 2002-01-08 | Innovata Biomend Limited | Inhaler |
EP1301187B1 (en) | 2000-07-04 | 2005-07-06 | Novo Nordisk A/S | Purine-2,6-diones which are inhibitors of the enzyme dipeptidyl peptidase iv (dpp-iv) |
US6363932B1 (en) | 2000-07-06 | 2002-04-02 | Clinical Technologies, Inc. | Aerosol enhancement device |
US6951215B1 (en) | 2000-07-14 | 2005-10-04 | Tufts University | Drug delivery device for animals |
US6360929B1 (en) | 2000-07-17 | 2002-03-26 | Mccarthy Madeleine | Medicinal atomizing inhaler pouch/retainer |
GB2364919A (en) | 2000-07-21 | 2002-02-13 | Cambridge Consultants | Inhalers |
AU2001284697A1 (en) | 2000-08-04 | 2002-02-18 | Dmi Biosciences, Inc. | Method of synthesizing diketopiperazines |
ES2381775T3 (es) | 2000-08-04 | 2012-05-31 | Dmi Biosciences, Inc. | Procedimiento del uso de dicetopiperazinas y composición que las contiene |
WO2002012265A1 (en) | 2000-08-05 | 2002-02-14 | Glaxo Group Limited | 6.ALPHA., 9.ALPHA.-DIFLUORO-17.ALPHA.-`(2-FURANYLCARBOXYL) OXY!-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT |
JP2004515467A (ja) | 2000-08-07 | 2004-05-27 | ネクター セラピューティックス | 吸入可能な、噴霧乾燥した、最少の凝集物を有する4−ヘリックスバンドルタンパク質粉末 |
AU2001283546A1 (en) | 2000-08-14 | 2002-02-25 | Advanced Inhalation Research, Inc. | Inhalation device and method |
US6704255B2 (en) | 2000-08-22 | 2004-03-09 | Ricoh Company, Ltd. | Lens actuator |
US6514482B1 (en) | 2000-09-19 | 2003-02-04 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
US6613308B2 (en) | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
USD460173S1 (en) | 2000-09-20 | 2002-07-09 | P.A. Knowledge Limited | Inhaler device |
EP1409051A2 (de) | 2000-09-20 | 2004-04-21 | Franco Del Bon | Inhalationsvorrichtung und zugehörige zerstäubungsvorrichtung |
SE517225C2 (sv) | 2000-09-21 | 2002-05-14 | Microdrug Ag | Optimering av en elektrostatiskt doserad inhalator för torrt pulver |
SE517228C2 (sv) | 2000-09-25 | 2002-05-14 | Microdrug Ag | Inhalator för torrt pulver med andningsaktivering |
SE517226C2 (sv) | 2000-09-25 | 2002-05-14 | Microdrug Ag | Inhalator med luftbroms för torrt pulver |
GB0023653D0 (en) | 2000-09-27 | 2000-11-08 | Cambridge Consultants | Device for dispensing particulate material |
WO2002026300A1 (en) | 2000-09-29 | 2002-04-04 | Pa Knowledge Limited | Pressure-responsive means and associated method of manufacture |
US6756062B2 (en) | 2000-11-03 | 2004-06-29 | Board Of Regents University Of Texas System | Preparation of drug particles using evaporation precipitation into aqueous solutions |
GB0029562D0 (en) | 2000-12-04 | 2001-01-17 | Novartis Ag | Organic compounds |
USD455208S1 (en) | 2000-12-05 | 2002-04-02 | Clinical Designs Limited | Inhaler |
WO2002047716A2 (en) | 2000-12-13 | 2002-06-20 | Eli Lilly And Company | Chronic treatment regimen using glucagon-like insulinotropic peptides |
CA2432175C (en) | 2000-12-21 | 2010-08-10 | Jayne E. Hastedt | Storage stable powder compositions of interleukin-4 receptor |
US6799572B2 (en) | 2000-12-22 | 2004-10-05 | Chrysalis Technologies Incorporated | Disposable aerosol generator system and methods for administering the aerosol |
US7077130B2 (en) | 2000-12-22 | 2006-07-18 | Chrysalis Technologies Incorporated | Disposable inhaler system |
US20020141946A1 (en) | 2000-12-29 | 2002-10-03 | Advanced Inhalation Research, Inc. | Particles for inhalation having rapid release properties |
EP1345629A2 (en) | 2000-12-29 | 2003-09-24 | Advanced Inhalation Research, Inc. | Particles for inhalation having sustained release properties |
US6626173B2 (en) | 2001-01-08 | 2003-09-30 | Iep Pharmaceutical Devices Inc. | Dry powder inhaler |
US6644309B2 (en) | 2001-01-12 | 2003-11-11 | Becton, Dickinson And Company | Medicament respiratory delivery device and method |
FI20010144A0 (fi) | 2001-01-24 | 2001-01-24 | Valtion Teknillinen | Menetelmä ja laite aerosolilähteiden tutkimiseksi |
AUPR272901A0 (en) | 2001-01-25 | 2001-02-22 | Gainful Plan Limited | Method of preparing biological materials and preparations produced using same |
GB2374010B (en) | 2001-02-26 | 2004-12-29 | Council Scient Ind Res | Novel vitamin B12 - biodegradable micro particulate conjugate carrier systems for peroral delivery of drugs, therapeutic peptides/proteins and vaccines |
DE60101451T2 (de) | 2001-03-05 | 2004-10-21 | Pera Ivo E | Inhaliergerät zur Verteilung von in einer Kapsel enthaltenen Medikamenten in Pulverform durch die Atemwege |
US6523536B2 (en) | 2001-03-12 | 2003-02-25 | Birdsong Medical Devices, Inc. | Dual-canister inhaler having a spacer and easy to operate lever mechanism |
US6698422B2 (en) | 2001-03-12 | 2004-03-02 | Birdsong Medical Devices, Inc. | Canister inhaler having a spacer and easy to operate lever mechanism and a flexible, elastic mouthpiece |
USD453264S1 (en) | 2001-03-30 | 2002-02-05 | Benjamin Acevedo, Jr. | Pouch for medical inhaler |
GB0108213D0 (en) | 2001-04-02 | 2001-05-23 | Glaxo Group Ltd | Medicament dispenser |
SE0101233L (sv) | 2001-04-05 | 2002-10-01 | Microdrug Ag | Förfarande och anordning för frigörande av pulver och inhalatoranordning för administrering av medicinskt pulver |
US6652838B2 (en) | 2001-04-05 | 2003-11-25 | Robert E. Weinstein | Method for treating diabetes mellitus |
EP1385856B1 (en) | 2001-04-11 | 2006-02-22 | Bristol-Myers Squibb Company | Amino acid complexes of c-aryl glucosides for treatment of diabetes and method |
US6766799B2 (en) | 2001-04-16 | 2004-07-27 | Advanced Inhalation Research, Inc. | Inhalation device |
US6447751B1 (en) | 2001-04-18 | 2002-09-10 | Robert E. Weinstein | Method and device for facilitating combined aerosol and oral treatments for diabetes mellitus |
WO2002085281A1 (en) | 2001-04-19 | 2002-10-31 | Technology Innovation Limited | Medicament container |
US7232897B2 (en) | 2001-04-24 | 2007-06-19 | Harvard University, President And Fellows Of Harvard College | Compositions and methods for modulating NH2-terminal Jun Kinase activity |
USD451597S1 (en) | 2001-04-24 | 2001-12-04 | G-Intek Co.,Ltd | Snivel inhaler |
JP4663906B2 (ja) | 2001-04-26 | 2011-04-06 | 富士フイルム株式会社 | セルロースアシレートフイルム |
JP2005506855A (ja) | 2001-05-10 | 2005-03-10 | ベクトゥラ デリバリー デバイシーズ リミテッド | 吸入器 |
OA13136A (en) | 2001-05-21 | 2006-12-13 | Nektar Therapeutics | Pulmonary administration of chemically modified insulin. |
SE0101825D0 (sv) | 2001-05-22 | 2001-05-22 | Astrazeneca Ab | An Inhalation device |
US7144863B2 (en) | 2001-06-01 | 2006-12-05 | Eli Lilly And Company | GLP-1 formulations with protracted time action |
US7035294B2 (en) | 2001-06-04 | 2006-04-25 | Calix Networks, Inc. | Backplane bus |
EG24184A (en) | 2001-06-15 | 2008-10-08 | Otsuka Pharma Co Ltd | Dry powder inhalation system for transpulmonary |
FI20011317A0 (fi) | 2001-06-20 | 2001-06-20 | Orion Corp | Jauheinhalaattori |
ATE301594T1 (de) | 2001-06-22 | 2005-08-15 | 3M Innovative Properties Co | Verfahren zur verbesserung des durchflusses einer aerosolformulierung in einem dosierventil für einen dosierinhalator |
US6681768B2 (en) | 2001-06-22 | 2004-01-27 | Sofotec Gmbh & Co. Kg | Powder formulation disintegrating system and method for dry powder inhalers |
US7414720B2 (en) | 2001-07-27 | 2008-08-19 | Herbert Wachtel | Measuring particle size distribution in pharmaceutical aerosols |
DE10136555A1 (de) | 2001-07-27 | 2003-02-13 | Boehringer Ingelheim Int | Optimierte Verfahren zur Bestimmung der Aerosol-Partikelgrößenverteilung und Vorrichtung zur Durchführung derartiger Verfahren |
GB0120018D0 (en) | 2001-08-16 | 2001-10-10 | Meridica Ltd | Pack containing medicament and dispensing device |
EP1432730A4 (en) | 2001-08-23 | 2006-10-11 | Lilly Co Eli | GLP-1 ANALOGUES (GLUCAGON-LIKE PEPTIDE 1) |
MXPA04001560A (es) | 2001-08-28 | 2004-05-17 | Lilly Co Eli | Premezclas de glp-1 e insulina basal. |
GB0121709D0 (en) | 2001-09-07 | 2001-10-31 | Imp College Innovations Ltd | Food inhibition agent |
JP2005507881A (ja) | 2001-09-17 | 2005-03-24 | グラクソ グループ リミテッド | 乾燥粉末医薬製剤 |
JP4261351B2 (ja) | 2001-09-19 | 2009-04-30 | アドヴェント ファーマセウティカルズ プロプライエタリー リミテッド | 吸入器 |
US6568390B2 (en) | 2001-09-21 | 2003-05-27 | Chrysalis Technologies Incorporated | Dual capillary fluid vaporizing device |
US6640050B2 (en) | 2001-09-21 | 2003-10-28 | Chrysalis Technologies Incorporated | Fluid vaporizing device having controlled temperature profile heater/capillary tube |
US7231919B2 (en) | 2001-09-28 | 2007-06-19 | Kurve Technology, Inc. | Particle dispersion device for nasal delivery |
US7093595B2 (en) | 2001-10-08 | 2006-08-22 | Eli Lilly And Company | Portable medication inhalation kit |
EP1436439B1 (en) | 2001-10-16 | 2008-07-02 | International Non-Toxic Composites Corp. | High density non-toxic composites comprising tungsten, another metal and polymer powder |
USD461239S1 (en) | 2001-10-18 | 2002-08-06 | Anna L. Cassidy | Inhaler sleeve with spring clip |
WO2003035099A1 (en) | 2001-10-19 | 2003-05-01 | Eli Lilly And Company | Biphasic mixtures of glp-1 and insulin |
WO2003035030A1 (en) | 2001-10-24 | 2003-05-01 | Pari Gmbh | Kit for the preparation of a pharmaceutical composition |
USD473298S1 (en) | 2001-11-01 | 2003-04-15 | Astrazeneca Ab | Inhaler refill |
CN1313617C (zh) | 2001-11-07 | 2007-05-02 | 曼康公司 | 编码靶相关抗原表位的表达载体及其设计方法 |
US7368102B2 (en) | 2001-12-19 | 2008-05-06 | Nektar Therapeutics | Pulmonary delivery of aminoglycosides |
US6994083B2 (en) | 2001-12-21 | 2006-02-07 | Trudell Medical International | Nebulizer apparatus and method |
GB0130857D0 (en) | 2001-12-22 | 2002-02-06 | Glaxo Group Ltd | Medicament dispenser |
USD479745S1 (en) | 2002-01-07 | 2003-09-16 | Aerogen, Inc. | Inhaler for dispensing medications |
USD474536S1 (en) | 2002-01-07 | 2003-05-13 | Aerogen, Inc. | Inhaler for dispensing medications |
USD469866S1 (en) | 2002-01-07 | 2003-02-04 | Aerogen, Inc. | Inhaler for dispensing medication |
US20030198666A1 (en) | 2002-01-07 | 2003-10-23 | Richat Abbas | Oral insulin therapy |
USD471273S1 (en) | 2002-01-07 | 2003-03-04 | Aerogen, Inc. | Inhaler for dispensing medication |
ITMI20020078A1 (it) | 2002-01-16 | 2003-07-16 | Fabrizio Niccolai | Dispositivo utilizzabile nel tratamento di affezzioni delle vie respiratorie |
WO2003061578A2 (en) | 2002-01-18 | 2003-07-31 | Mannkind Corporation | Compositions for treatment or prevention of bioterrorism |
US7258118B2 (en) | 2002-01-24 | 2007-08-21 | Sofotec Gmbh & Co, Kg | Pharmaceutical powder cartridge, and inhaler equipped with same |
EP2409569B1 (en) | 2002-02-20 | 2017-08-16 | Emisphere Technologies, Inc. | Method for administering GLP-1 molecules |
US6591832B1 (en) | 2002-02-21 | 2003-07-15 | Saint-Gobain Calmar Inc. | Dry powder dispenser |
DE60318938T2 (de) | 2002-03-20 | 2009-01-22 | Mannkind Corp., Valencia | Inhalationsgerät |
US7008644B2 (en) | 2002-03-20 | 2006-03-07 | Advanced Inhalation Research, Inc. | Method and apparatus for producing dry particles |
US20030235538A1 (en) | 2002-04-09 | 2003-12-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Method for the administration of an anticholinergic by inhalation |
US20030194420A1 (en) | 2002-04-11 | 2003-10-16 | Richard Holl | Process for loading a drug delivery device |
USD475133S1 (en) | 2002-04-18 | 2003-05-27 | Mcluckie Lynne E. | Luminescent-colored inhaler |
US7316748B2 (en) | 2002-04-24 | 2008-01-08 | Wisconsin Alumni Research Foundation | Apparatus and method of dispensing small-scale powders |
US6830046B2 (en) | 2002-04-29 | 2004-12-14 | Hewlett-Packard Development Company, L.P. | Metered dose inhaler |
US20040151059A1 (en) | 2002-05-01 | 2004-08-05 | Roberts Ii William Leroy | Deagglomerator apparatus and method |
USD478983S1 (en) | 2002-05-01 | 2003-08-26 | Chrysalis Technologies Incorporated | Inhaler |
JP2005526126A (ja) | 2002-05-07 | 2005-09-02 | ノボ ノルディスク アクティーゼルスカブ | インスリンアスパルト及びインスリンデテミアを含む可溶性製剤 |
US6889690B2 (en) | 2002-05-10 | 2005-05-10 | Oriel Therapeutics, Inc. | Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages |
USD473640S1 (en) | 2002-05-13 | 2003-04-22 | Iep Pharmaceutical Devices Inc. | Breath actuated inhaler |
USD492769S1 (en) | 2002-05-24 | 2004-07-06 | Glaxosmithkline K.K. | Lens for an inhaler |
USD477665S1 (en) | 2002-06-12 | 2003-07-22 | Microdrug Ag | Inhaler |
AU154760S (en) | 2002-06-20 | 2004-03-02 | Astrazeneca Ab | Inhaler |
US7947742B2 (en) | 2002-06-28 | 2011-05-24 | Civitas Therapeutics, Inc. | Inhalable epinephrine |
US20060003316A1 (en) | 2002-07-15 | 2006-01-05 | John Simard | Immunogenic compositions derived from poxviruses and methods of using same |
GB0217198D0 (en) | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
GB0217382D0 (en) | 2002-07-26 | 2002-09-04 | Pfizer Ltd | Process for making orally consumable dosage forms |
ATE326251T1 (de) | 2002-07-31 | 2006-06-15 | Chiesi Farma Spa | Pulverinhalator |
USD489448S1 (en) | 2002-07-31 | 2004-05-04 | Advanced Inhalations Revolutions, Inc. | Vaporization apparatus |
DE10235168A1 (de) | 2002-08-01 | 2004-02-12 | Aventis Pharma Deutschland Gmbh | Verfahren zur Reinigung von Preproinsulin |
WO2004012672A2 (en) | 2002-08-01 | 2004-02-12 | Mannkind Corporation | Cell transport compositions and uses thereof |
US20080260838A1 (en) | 2003-08-01 | 2008-10-23 | Mannkind Corporation | Glucagon-like peptide 1 (glp-1) pharmaceutical formulations |
US20150283213A1 (en) | 2002-08-01 | 2015-10-08 | Mannkind Corporation | Method for treating hyperglycemia with glp-1 |
US20040038865A1 (en) | 2002-08-01 | 2004-02-26 | Mannkind Corporation | Cell transport compositions and uses thereof |
GB0315791D0 (en) | 2003-07-07 | 2003-08-13 | 3M Innovative Properties Co | Two component molded valve stems |
US20040121964A1 (en) | 2002-09-19 | 2004-06-24 | Madar David J. | Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
USD509296S1 (en) | 2002-09-21 | 2005-09-06 | Aventis Pharma Limited | Inhaler |
JP2004121061A (ja) | 2002-10-01 | 2004-04-22 | Sanei Gen Ffi Inc | 粉末組成物の製造方法 |
CN1684732B (zh) | 2002-10-11 | 2010-04-21 | 大冢制药株式会社 | 粉末吸入器 |
ITMO20020297A1 (it) | 2002-10-16 | 2004-04-17 | Roberto Oliva | Inalatore per preparati monodose in capsule. |
CN1176649C (zh) | 2002-10-16 | 2004-11-24 | 上海医药工业研究院 | 舒马普坦干粉吸入剂及其制备方法 |
AU2003286796A1 (en) | 2002-10-31 | 2004-06-07 | Umd, Inc. | Therapeutic compositions for drug delivery to and through covering epithelia |
AU2003276447A1 (en) | 2002-11-04 | 2004-06-07 | Cambridge Consultants Limited | Inhalers |
USD493220S1 (en) | 2002-11-06 | 2004-07-20 | Merck Patent Gmbh | Inhaler |
US20080015457A1 (en) | 2002-11-07 | 2008-01-17 | Silva Carlos D | Device for Monitoring Respiratory Movements |
USD483860S1 (en) | 2002-11-12 | 2003-12-16 | Pari Gmbh Spezialisten Fur Effektive Inhalation | Electronic inhaler and control unit |
US6904907B2 (en) | 2002-11-19 | 2005-06-14 | Honeywell International Inc. | Indirect flow measurement through a breath-operated inhaler |
US7913688B2 (en) | 2002-11-27 | 2011-03-29 | Alexza Pharmaceuticals, Inc. | Inhalation device for producing a drug aerosol |
US20040138099A1 (en) | 2002-11-29 | 2004-07-15 | Draeger Eberhard Kurt | Insulin administration regimens for the treatment of subjects with diabetes |
JP2006507876A (ja) | 2002-12-02 | 2006-03-09 | ザ・ガバナーズ・オブ・ザ・ユニバーシティ・オブ・アルバータ | 吸入用粉末の解凝集のための装置及び方法 |
US7284553B2 (en) | 2002-12-12 | 2007-10-23 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Powder inhaler comprising a chamber for a capsule for taking up a non-returnable capsule being filled with an active ingredient |
TWI313181B (en) | 2002-12-13 | 2009-08-11 | Otsuka Pharma Co Ltd | Inhalation device for transpulmonary administration |
MXPA05006572A (es) | 2002-12-17 | 2005-12-14 | Nastech Pharm Co | Composiciones y metodos para la administracion mejorada por via mucosa de peptidos fijadores al receptor de y2 y metodos para tratar y prevenir la obesidad. |
US6941947B2 (en) | 2002-12-18 | 2005-09-13 | Quadrant Technologies Limited | Unit dose dry powder inhaler |
US7185650B2 (en) | 2002-12-19 | 2007-03-06 | Arie Huber | Systems and methods for determining a minimum effective dose of an inhaled drug for an individual patient at a given time |
US6962006B2 (en) | 2002-12-19 | 2005-11-08 | Acusphere, Inc. | Methods and apparatus for making particles using spray dryer and in-line jet mill |
WO2004060387A1 (en) | 2002-12-27 | 2004-07-22 | Diobex, Inc. | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
DE10300032B3 (de) | 2003-01-03 | 2004-05-27 | E. Braun Gmbh | Pulverinhalator |
GB0309154D0 (en) | 2003-01-14 | 2003-05-28 | Aventis Pharma Inc | Use of insulin glargine to reduce or prevent cardiovascular events in patients being treated for dysglycemia |
US20040187869A1 (en) | 2003-01-17 | 2004-09-30 | Schering Corporation | Training device for medicament inhalers |
EP1605916A4 (en) | 2003-02-12 | 2012-02-22 | R & P Korea Co Ltd | SOLUBENT SOLVENT SYSTEM WITH SOLUBLE PEEL WITH IMPROVED ELUTION RATE |
GB0303870D0 (en) | 2003-02-20 | 2003-03-26 | Norton Healthcare Ltd | Pre-metered dose magazine for breath-actuated dry powder inhaler |
US20040171518A1 (en) | 2003-02-27 | 2004-09-02 | Medtronic Minimed, Inc. | Compounds for protein stabilization and methods for their use |
CN1780655B (zh) | 2003-03-04 | 2010-12-15 | 诺顿·希尔思凯尔有限公司 | 具有指示内部药物容器状态的显示器的药物分配设备 |
BRPI0408097A (pt) | 2003-03-04 | 2006-02-14 | Technology Dev Company Ltd | composição de insulina oral e processos para a produção e para o uso da mesma |
AU2004220544B2 (en) | 2003-03-06 | 2010-06-17 | Emisphere Technologies, Inc. | Oral insulin therapies and protocol |
WO2004080482A2 (en) | 2003-03-11 | 2004-09-23 | Institut De Cardiologie De Montréal / | Use of angiotensin converting enzyme (ace) inhibitors to prevent diabetes in a subject with chronic heart failure |
USD499802S1 (en) | 2003-04-01 | 2004-12-14 | Chiesi Farmaceutici S.P.A. | Powder inhaler |
DK1615689T3 (da) | 2003-04-09 | 2016-03-14 | Novartis Ag | Apparatur til dannelse af en aerosol og omfattende en opretningsføring til punktering af en kapsel |
US20040204439A1 (en) | 2003-04-14 | 2004-10-14 | Staniforth John Nicholas | Composition, device, and method for treating sexual dysfunction via inhalation |
EP1468935A1 (de) | 2003-04-16 | 2004-10-20 | Alcan Technology & Management Ltd. | Blisterverpackung |
AU155845S (en) | 2003-05-15 | 2004-07-13 | Glaxo Group Ltd | A dispensing device for example an inhaler device |
AU2004241101B2 (en) | 2003-05-15 | 2010-05-13 | Ampio Pharmaceuticals, Inc. | Treatment of T-cell mediated diseases |
AU155633S (en) | 2003-05-16 | 2004-06-01 | Henkel Kgaa | Blister pack |
US20070006876A1 (en) | 2003-05-16 | 2007-01-11 | University Of Alberta | Add-on spacer design concept for dry-powder inhalers |
GB0312007D0 (en) | 2003-05-24 | 2003-07-02 | Innovata Biomed Ltd | Container |
ES2328697T5 (es) | 2003-06-02 | 2017-07-25 | Novartis Vaccines And Diagnostics, Inc. | Composiciones inmunogénicas basadas en micropartículas que comprenden toxoide adsorbido y un antígeno que contiene un polisacárido |
AU2004249166B2 (en) | 2003-06-13 | 2008-10-09 | Alkermes, Inc. | Low dose pharmaceutical powders for inhalation |
US7001622B1 (en) | 2003-06-30 | 2006-02-21 | Robert Berndt | Composition and method for treatment and prevention of pruritis |
GB0315509D0 (en) | 2003-07-02 | 2003-08-06 | Meridica Ltd | Dispensing device |
AU158576S (en) | 2003-07-05 | 2006-08-22 | Clinical Designs Ltd | Inhaler |
US7462367B2 (en) | 2003-07-11 | 2008-12-09 | Boehringer Ingelheim International Gmbh | Anticholinergic powder formulations for inhalation |
US8921311B2 (en) | 2003-08-01 | 2014-12-30 | Mannkind Corporation | Method for treating hyperglycemia |
USD569967S1 (en) | 2003-08-06 | 2008-05-27 | Meridica Limited | Inhaler |
US20050043247A1 (en) | 2003-08-18 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Spray-dried amorphous BIBN 4096, process for preparing and the use thereof as inhalative |
DE10338402A1 (de) | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Sprühgetrocknetes, amorphes BIBN 4096, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum |
US20050056535A1 (en) | 2003-09-15 | 2005-03-17 | Makoto Nagashima | Apparatus for low temperature semiconductor fabrication |
DE10343668A1 (de) | 2003-09-18 | 2005-04-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Arzneimittelblister |
CA2539632A1 (en) | 2003-10-16 | 2005-04-28 | Cara Therapeutics, Inc. | Amide or thioamide derivatives and their use in the treatment of pain |
GB2398065A (en) | 2003-10-16 | 2004-08-11 | Bespak Plc | Dispensing apparatus |
US20050187749A1 (en) | 2003-10-24 | 2005-08-25 | Judy Singley | Method, system, and computer program for performing carbohydrate/insulin calculation based upon food weight |
USD511208S1 (en) | 2003-10-24 | 2005-11-01 | Valois Sas | Metered dose inhaler |
US7451761B2 (en) | 2003-10-27 | 2008-11-18 | Oriel Therapeutics, Inc. | Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances |
US7377277B2 (en) | 2003-10-27 | 2008-05-27 | Oriel Therapeutics, Inc. | Blister packages with frames and associated methods of fabricating dry powder drug containment systems |
WO2005041848A2 (en) | 2003-10-27 | 2005-05-12 | Oriel Therapeutics, Inc. | Dry powder drug containment system packages with tabs, inhalers and associated methods |
US20050147581A1 (en) | 2003-11-19 | 2005-07-07 | The Board Of Trustees Of The University Of Illinois | Macromolecular drug complexes having improved stability and therapeutic use of the same |
SE0303269L (sv) | 2003-12-03 | 2005-06-04 | Microdrug Ag | Medicinsk produkt |
GB0329884D0 (en) | 2003-12-23 | 2004-01-28 | Glaxo Group Ltd | Method |
CN101027082A (zh) | 2004-01-12 | 2007-08-29 | 曼恩坎德公司 | 降低2型糖尿病患者血清胰岛素原水平的方法 |
US20070027063A1 (en) | 2004-01-12 | 2007-02-01 | Mannkind Corporation | Method of preserving the function of insulin-producing cells |
WO2005072803A1 (en) | 2004-01-16 | 2005-08-11 | Biodel, Inc. | Sublingual drug delivery device |
DE102004006450B4 (de) | 2004-02-05 | 2012-09-27 | Ing. Erich Pfeiffer Gmbh | Dosiervorrichtung |
DE102004008141A1 (de) | 2004-02-19 | 2005-09-01 | Abbott Gmbh & Co. Kg | Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren |
USD512777S1 (en) | 2004-02-19 | 2005-12-13 | Chrysalis Technologies Incorporated | Inhaler |
AU2005216205B2 (en) | 2004-02-24 | 2010-07-15 | Microdose Therapeutx, Inc. | Directional flow sensor inhaler |
BRPI0507884A (pt) | 2004-02-24 | 2007-08-07 | Microdose Technologies Inc | método e equipamento para administração de medicamento com base em jato sintético |
ATE433746T1 (de) | 2004-03-12 | 2009-07-15 | Biodel Inc | Insulinzusammensetzungen mit verbesserter wirkstoffabsorption |
ITMO20040060A1 (it) | 2004-03-18 | 2004-06-18 | Roberto Oliva | Inalatore per preparati in polvere |
USD515696S1 (en) | 2004-03-19 | 2006-02-21 | Innovata Biomed Limited | Inhaler |
EP1734938B1 (en) | 2004-03-26 | 2012-06-20 | Universita' Degli Studi Di Parma | Insulin highly respirable microparticles |
USD533268S1 (en) | 2004-04-18 | 2006-12-05 | Bahram Olfati | Inhaler |
CA2562386C (en) | 2004-04-21 | 2014-11-18 | Innovata Biomed Limited | Inhaler |
EP1745247B1 (en) | 2004-04-23 | 2015-11-11 | Philip Morris Products S.a.s. | Aerosol generators and methods for producing aerosols |
WO2005102428A1 (en) | 2004-04-23 | 2005-11-03 | The Governors Of The University Of Alberta | Enhanced drug delivery for inhaled aerosols |
GB0410712D0 (en) | 2004-05-13 | 2004-06-16 | Novartis Ag | Organic compounds |
USD527817S1 (en) | 2004-05-13 | 2006-09-05 | Novartis Ag | Inhaler |
US20050265927A1 (en) | 2004-05-17 | 2005-12-01 | Yale University | Intranasal delivery of nucleic acid molecules |
TW200607538A (en) | 2004-05-19 | 2006-03-01 | Cipla Ltd | Medicament inhaler device |
USD529604S1 (en) | 2004-05-28 | 2006-10-03 | Quadrant Technologies Limited | Dry powder inhaler |
USD548833S1 (en) | 2004-05-28 | 2007-08-14 | Quadrant Technologies Limited | Dry powder inhaler |
WO2005120616A1 (en) | 2004-06-07 | 2005-12-22 | Mederio Ag | Securing dose quality of inhalable drug |
SE528190C2 (sv) | 2004-06-07 | 2006-09-19 | Mederio Ag | Inhalator |
US20060000469A1 (en) | 2004-07-02 | 2006-01-05 | Tseng Daniel C | Nebulizing apparatus for medical use with improved nozzle positioning structure |
KR20070048201A (ko) | 2004-07-23 | 2007-05-08 | 인터큐어 엘티디 | 비접촉 마이크로폰을 사용한 호흡 패턴 판별 장치 및 방법 |
EP1778322B1 (en) | 2004-07-26 | 2017-11-22 | 1355540 Ontario Inc. | Powder inhaler featuring reduced compaction inhaler |
CN101035568A (zh) | 2004-08-03 | 2007-09-12 | 比奥雷克西斯技术股份有限公司 | 使用包含glp-1的运铁蛋白融合蛋白的组合治疗 |
EP1786784B1 (en) | 2004-08-20 | 2010-10-27 | MannKind Corporation | Catalysis of diketopiperazine synthesis |
CA2578175C (en) | 2004-08-23 | 2014-10-14 | Mannkind Corporation | Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery |
BRPI0514410A (pt) | 2004-08-23 | 2008-06-10 | Mannkind Corp | fornecimento pulmonar de inibidores de fosfodiesterase do tipo 5 |
GB0419849D0 (en) | 2004-09-07 | 2004-10-13 | Pfizer Ltd | Pharmaceutical combination |
US8210171B2 (en) | 2004-09-13 | 2012-07-03 | Oriel Therapeutics, Inc. | Tubular dry powder drug containment systems, associated inhalers and methods |
WO2006031775A2 (en) | 2004-09-13 | 2006-03-23 | Oriel Therapeutics, Inc. | Dry powder inhalers that inhibit agglomeration, related devices and methods |
USD537936S1 (en) | 2004-09-15 | 2007-03-06 | Glaxo Group Limited | Cap with an extension, particularly for a dust cap of a metered dose inhaler |
USD537522S1 (en) | 2004-09-15 | 2007-02-27 | Glaxo Group Limited | Telescopic strap, particularly for a dust cap of a metered dose inhaler |
USD518170S1 (en) | 2004-09-28 | 2006-03-28 | Vectura, Ltd. | Inhaler |
AU2005291427A1 (en) | 2004-10-06 | 2006-04-13 | Boehringer Ingelheim International Gmbh | Dispensing device, storage device and method for dispensing powder |
US7469696B2 (en) | 2004-10-13 | 2008-12-30 | Hewlett-Packard Development Company, L.P. | Thermal drop generator |
USD515924S1 (en) | 2004-11-01 | 2006-02-28 | Warner-Lambert Company Llc | Blister card |
DE102005033398A1 (de) | 2004-11-10 | 2006-05-11 | Alfred Von Schuckmann | Inhalier-Gerät |
EP1827381A1 (en) | 2004-12-03 | 2007-09-05 | Mederio AG | A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation |
SE0402976L (sv) | 2004-12-03 | 2006-06-04 | Mederio Ag | Medicinsk produkt |
GB0427028D0 (en) | 2004-12-09 | 2005-01-12 | Cambridge Consultants | Dry powder inhalers |
BRPI0519241A2 (pt) | 2004-12-22 | 2009-01-06 | Centocor Inc | agonistas, composiÇÕes, mÉtodos e usos de glp-1 |
MX2007008379A (es) | 2005-01-10 | 2008-02-19 | Mannkind Corp | Metodos y composiciones para minimizar la acumulacion de insulina inhlable en los pulmones. |
US20060165756A1 (en) | 2005-01-27 | 2006-07-27 | Catani Steven J | Method for weight management |
USD538423S1 (en) | 2005-02-04 | 2007-03-13 | Berube-White | Panda bear inhaler |
GB0503738D0 (en) | 2005-02-23 | 2005-03-30 | Optinose As | Powder delivery devices |
JP4656397B2 (ja) | 2005-03-31 | 2011-03-23 | 株式会社吉野工業所 | 粉体用容器 |
CN100431634C (zh) | 2005-04-04 | 2008-11-12 | 陈庆堂 | 干粉气溶胶化吸入器 |
US7762953B2 (en) | 2005-04-20 | 2010-07-27 | Adidas Ag | Systems and methods for non-invasive physiological monitoring of non-human animals |
US7694676B2 (en) | 2005-04-22 | 2010-04-13 | Boehringer Ingelheim Gmbh | Dry powder inhaler |
MX2007013356A (es) | 2005-04-27 | 2008-03-26 | Baxter Int | Microparticulas modificadas en la superficie y metodos de formacion y uso de las mismas. |
US7219664B2 (en) | 2005-04-28 | 2007-05-22 | Kos Life Sciences, Inc. | Breath actuated inhaler |
AU2006241543A1 (en) | 2005-05-02 | 2006-11-09 | Astrazeneca Ab | An arrangement and a method for opening a cavity, a medical package and a dispensing device |
USD544093S1 (en) | 2005-06-02 | 2007-06-05 | Bang & Olufsen A/S | Inhaler |
CN107496925A (zh) | 2005-06-17 | 2017-12-22 | 威斯康星校友研究基金会 | 在癌症化疗和放疗时保护细胞的局部血管收缩剂制品和方法 |
EP1901793A1 (en) | 2005-07-13 | 2008-03-26 | Cipla Ltd. | Inhaler device |
US8763605B2 (en) | 2005-07-20 | 2014-07-01 | Manta Devices, Llc | Inhalation device |
USD550835S1 (en) | 2005-07-22 | 2007-09-11 | Omron Healthcare Co., Ltd. | Atomizer for inhaler |
WO2007016600A2 (en) | 2005-08-01 | 2007-02-08 | Mannkind Corporation | Method of preserving the function of insulin-producing cells |
WO2007019229A1 (en) | 2005-08-05 | 2007-02-15 | 3M Innovative Properties Company | Compositions exhibiting improved flowability |
CA2618520C (en) | 2005-08-25 | 2015-01-27 | Oriel Therapeutics, Inc. | Drug containment systems with sticks, related kits, dry powder inhalers and methods |
EP2275095A3 (en) | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
WO2008048234A2 (en) | 2005-08-26 | 2008-04-24 | North Carolina State University | Inhaler system for targeted maximum drug-aerosol delivery |
JP2007061281A (ja) | 2005-08-30 | 2007-03-15 | Hitachi Ltd | 吸入量測定システム |
WO2007030706A1 (en) | 2005-09-08 | 2007-03-15 | New England Medical Center Hospitals, Inc. | Fragments of the glucagon-like peptide-i and uses thereof |
US7803404B2 (en) | 2005-09-14 | 2010-09-28 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces |
WO2007041481A1 (en) | 2005-09-29 | 2007-04-12 | Biodel, Inc. | Rapid acting and prolonged acting insulin preparations |
US20070074989A1 (en) | 2005-09-30 | 2007-04-05 | Musculoskeletal Transplant Foundation | Container for lyophilization and storage of tissue |
GB0520794D0 (en) | 2005-10-12 | 2005-11-23 | Innovata Biomed Ltd | Inhaler |
ITMI20051999A1 (it) | 2005-10-21 | 2007-04-22 | Eratech S R L | Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita' |
US8039432B2 (en) | 2005-11-09 | 2011-10-18 | Conjuchem, Llc | Method of treatment of diabetes and/or obesity with reduced nausea side effect |
AR058289A1 (es) | 2005-12-12 | 2008-01-30 | Glaxo Group Ltd | Colector para ser usado en dispensador de medicamento |
EP2364735A3 (en) | 2005-12-16 | 2012-04-11 | Nektar Therapeutics | Branched PEG conjugates of GLP-1 |
USD557799S1 (en) | 2006-01-25 | 2007-12-18 | Valois S.A.S. | Inhaler |
GB0602897D0 (en) | 2006-02-13 | 2006-03-22 | Jagotec Ag | Improvements In Or Relating To Dry Powder Inhaler Devices |
US7959609B2 (en) | 2006-02-14 | 2011-06-14 | Battelle Memorial Institute | Accurate metering system |
BRPI0707991B8 (pt) | 2006-02-22 | 2021-05-25 | Mannkind Corp | métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco |
CA2638800A1 (en) | 2006-02-22 | 2007-09-07 | Merck & Co., Inc. | Oxyntomodulin derivatives |
DE102006010089A1 (de) | 2006-02-24 | 2007-10-18 | Aha-Kunststofftechnik Gmbh | Trockenpulver-Inhalator |
US8037880B2 (en) | 2006-04-07 | 2011-10-18 | The University Of Western Ontario | Dry powder inhaler |
EP1844806A1 (de) | 2006-04-13 | 2007-10-17 | Boehringer Ingelheim Pharma GmbH | Medikamenten-Ausgabevorrichtung, Medikamentenmagazin dafür, und Verfahren zur Entnahme eines Medikaments aus einer Medikamentenkammer |
EP1844809A1 (de) | 2006-04-13 | 2007-10-17 | Boehringer Ingelheim Pharma GmbH & Co. KG | Medikamentenmagazin für einen Inhalator, sowie Mehrdosispulverinhalator |
WO2007121411A2 (en) | 2006-04-14 | 2007-10-25 | Mannkind Corporation | Glucagon-like peptide 1(glp-1) pharmaceutical formulations |
GR1005620B (el) | 2006-05-09 | 2007-09-03 | Βελτιωση συσκευης εισπνοων ξηρης σκονης | |
EP2022445A1 (en) | 2006-05-10 | 2009-02-11 | S.K.I.Net Inc. | Anesthetic system for small animal |
DE102006021978A1 (de) | 2006-05-10 | 2007-11-15 | Robert Bosch Gmbh | Vorrichtung und Verfahen zum Verstärken eines Blisters |
PT103481B (pt) | 2006-05-16 | 2008-08-01 | Hovione Farmaciencia S A | Inalador de uso simples e método de inalação |
GB0611659D0 (en) | 2006-06-13 | 2006-07-19 | Cambridge Consultants | Dry powder inhalers |
GB0611656D0 (en) | 2006-06-13 | 2006-07-19 | Cambridge Consultants | Dry powder inhalers |
UY30418A1 (es) | 2006-06-16 | 2008-01-31 | Cipla Ltd | Inhalador de polvo seco mejorado |
US8201555B2 (en) | 2006-06-27 | 2012-06-19 | Brintech International Limited | Inhaler |
RU2436599C2 (ru) | 2006-06-27 | 2011-12-20 | Оцука Фармасьютикал Ко., Лтд. | Порошковый ингалятор |
GB0613161D0 (en) | 2006-06-30 | 2006-08-09 | Novartis Ag | Organic Compounds |
US20090250058A1 (en) | 2006-07-14 | 2009-10-08 | Astrazeneca Ab | Inhalation System and Delivery Device for the Administration of a Drug in the Form of Dry Powder |
CN101511823B (zh) | 2006-08-04 | 2014-07-30 | 麦那思制药(加拿大)有限公司 | 多功能生物活性化合物 |
GB0616299D0 (en) | 2006-08-16 | 2006-09-27 | Cambridge Consultants | Drug Capsules for dry power inhalers |
US20080066739A1 (en) | 2006-09-20 | 2008-03-20 | Lemahieu Edward | Methods and systems of delivering medication via inhalation |
US20080108574A1 (en) | 2006-09-27 | 2008-05-08 | Braincells, Inc. | Melanocortin receptor mediated modulation of neurogenesis |
US7842662B2 (en) | 2006-11-10 | 2010-11-30 | Cara Therapeutics, Inc. | Synthetic peptide amide dimers |
US8236766B2 (en) | 2006-11-10 | 2012-08-07 | Cara Therapeutics, Inc. | Uses of synthetic peptide amides |
BRPI0718651B8 (pt) | 2006-11-10 | 2021-05-25 | Cara Therapeutics Inc | amidas peptídicas sintéticas |
WO2008060484A2 (en) | 2006-11-10 | 2008-05-22 | Proveris Scientific Corporation | Automated nasal spray pump testing |
US7713937B2 (en) | 2006-11-10 | 2010-05-11 | Cara Therapeutics, Inc. | Synthetic peptide amides and dimeric forms thereof |
USD549111S1 (en) | 2006-12-06 | 2007-08-21 | Eveready Battery Company, Inc. | Zinc-air hearing aid battery package |
USD548619S1 (en) | 2006-12-06 | 2007-08-14 | Eveready Battery Company, Inc. | Zinc-air hearing aid battery package |
USD548618S1 (en) | 2006-12-06 | 2007-08-14 | Eveready Battery Company, Inc. | Zinc-air hearing aid battery package |
US8567394B2 (en) | 2006-12-22 | 2013-10-29 | Almirall, S.A. | Inhalation device for drugs in powder form |
WO2008092864A1 (en) | 2007-01-29 | 2008-08-07 | Novo Nordisk A/S | Method and devices for aerosolizing a drug formulation |
US8172817B2 (en) | 2007-01-31 | 2012-05-08 | Allegiance Corporation | Liquid collection system and related methods |
KR20150116465A (ko) | 2007-02-15 | 2015-10-15 | 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 | 글루카곤/glp-1 수용체 공동-항진물질 |
US8196576B2 (en) | 2007-02-28 | 2012-06-12 | Microdose Therapeutx, Inc. | Inhaler |
WO2009005546A1 (en) | 2007-03-05 | 2009-01-08 | Board of Governors for Higher Education, State of Rhode Island and the Providence Plantations | High efficiency mouthpiece/adaptor for inhalers |
JP2008212436A (ja) | 2007-03-06 | 2008-09-18 | Canon Inc | 吸入装置 |
US8146745B2 (en) | 2007-03-09 | 2012-04-03 | Cardpak, Inc. | Environmentally separable packaging device with attaching base |
GB0704928D0 (en) | 2007-03-14 | 2007-04-25 | Cambridge Consultants | Dry powder inhalers |
WO2009076325A2 (en) | 2007-04-11 | 2009-06-18 | Starr Life Sciences Corp. | Noninvasive photoplethysmographic sensor platform for mobile animals |
JP5351884B2 (ja) | 2007-04-23 | 2013-11-27 | インターシア セラピューティクス,インコーポレイティド | インスリン分泌促進性ペプチドの懸濁製剤及び使用 |
USD577815S1 (en) | 2007-04-30 | 2008-09-30 | Sun Pharma Advanced Research Company Limited | Inhaler |
JP5356367B2 (ja) | 2007-04-30 | 2013-12-04 | サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッド | 吸入装置 |
USD583463S1 (en) | 2007-04-30 | 2008-12-23 | Sun Pharma Advanced Research Company Limited | Inhaler |
EP1992378A1 (en) | 2007-05-16 | 2008-11-19 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device |
CN105776119B (zh) | 2007-05-16 | 2019-04-23 | 神秘制药公司 | 组成物单位剂量分配容器 |
USD579549S1 (en) | 2007-06-07 | 2008-10-28 | Novartis Ag | Inhaler |
ES2439255T3 (es) | 2007-06-21 | 2014-01-22 | Cara Therapeutics, Inc. | Imidazoheterociclos sustituidos |
WO2009009013A2 (en) | 2007-07-06 | 2009-01-15 | Manta Devices, Llc | Inhalation devices for storing and delivering medicament |
US20090084379A1 (en) | 2007-10-02 | 2009-04-02 | Baxter International Inc. | Dry powder inhaler |
EP2048112A1 (en) | 2007-10-09 | 2009-04-15 | Kemira Kemi AB | Use of a nozzle for manufacturing sodium percarbonate |
JP5813323B2 (ja) | 2007-10-24 | 2015-11-17 | マンカインド コーポレイション | 活性薬剤の送達方法 |
US8785396B2 (en) | 2007-10-24 | 2014-07-22 | Mannkind Corporation | Method and composition for treating migraines |
CN101969927A (zh) | 2007-10-24 | 2011-02-09 | 曼金德公司 | 预防glp-1不良影响的方法 |
JP5350388B2 (ja) | 2007-10-25 | 2013-11-27 | ノバルティス アーゲー | 単位用量薬物パッケージの粉体調整 |
GB0721394D0 (en) | 2007-10-31 | 2007-12-12 | Vectura Group Plc | Compositions for trating parkinson's disease |
EP2205302A4 (en) | 2007-11-06 | 2010-12-29 | 3M Innovative Properties Co | MEDICAL INHALATION DEVICES AND COMPONENTS THEREOF |
EP2060268A1 (en) | 2007-11-15 | 2009-05-20 | Novo Nordisk A/S | Pharmaceutical compositions for pulmonary or nasal delivery of peptides |
USD594753S1 (en) | 2007-12-14 | 2009-06-23 | The Procter & Gamble Company | Blister card |
EP2230934B8 (en) | 2007-12-14 | 2012-10-24 | AeroDesigns, Inc | Delivering aerosolizable food products |
JP2011507593A (ja) | 2007-12-20 | 2011-03-10 | アストラゼネカ・アクチエボラーグ | 粉末854を脱凝集解体する装置ならびに方法 |
US7584846B2 (en) | 2007-12-21 | 2009-09-08 | S.C. Johnson & Son, Inc. | Shaped packaging for a refill |
CA2728808A1 (en) | 2008-02-01 | 2009-08-06 | Vectura Limited | Pulmonary formulations of triptans |
GB0802028D0 (en) | 2008-02-05 | 2008-03-12 | Dunne Stephen T | Powder inhaler flow regulator |
USD614045S1 (en) | 2008-02-22 | 2010-04-20 | Ima Safe S.R.L. | Blister packaging |
CN101980743B (zh) | 2008-03-27 | 2014-04-02 | 曼金德公司 | 干燥粉末吸入系统 |
WO2009125423A2 (en) | 2008-04-07 | 2009-10-15 | National Institute Of Immunology | Compositions useful for the treatment of diabetes and other chronic disorder |
BRPI0913021A2 (pt) | 2008-05-15 | 2015-10-13 | Novartis Ag | distribuição pulmonar de uma fluoroquinolona |
USD597418S1 (en) | 2008-05-22 | 2009-08-04 | Wm. Wrigley Jr. Company | Blister card |
USD598785S1 (en) | 2008-05-22 | 2009-08-25 | Wm. Wrigley Jr. Company | Blister card |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
USD605753S1 (en) | 2008-06-13 | 2009-12-08 | Mannkind Corporation | Cartridge for a dry powder inhaler |
USD604832S1 (en) | 2008-06-13 | 2009-11-24 | Mannkind Corporation | Cartridge for a dry powder inhaler |
USD635241S1 (en) | 2008-06-13 | 2011-03-29 | Mannkind Corporation | Dry powder inhaler |
USD605752S1 (en) | 2008-06-13 | 2009-12-08 | Mannkind Corporation | Dry powder inhaler |
USD604833S1 (en) | 2008-06-13 | 2009-11-24 | Mannkind Corporation | Dry powder inhaler |
USD597657S1 (en) | 2008-06-13 | 2009-08-04 | Mannkind Corporation | Dry powder inhaler |
USD614760S1 (en) | 2008-06-13 | 2010-04-27 | Mannkind Corporation | Dry powder inhaler |
USD613849S1 (en) | 2008-06-13 | 2010-04-13 | Mannkind Corporation | Cartridge for a dry powder inhaler |
EP2570147B1 (en) | 2008-06-13 | 2017-10-18 | MannKind Corporation | A dry powder inhaler and system for drug delivery |
US9364619B2 (en) | 2008-06-20 | 2016-06-14 | Mannkind Corporation | Interactive apparatus and method for real-time profiling of inhalation efforts |
TWI614024B (zh) | 2008-08-11 | 2018-02-11 | 曼凱公司 | 超快起作用胰島素之用途 |
USD629887S1 (en) | 2008-12-01 | 2010-12-28 | Mannkind Corporation | Dry powder inhaler |
USD629886S1 (en) | 2008-12-01 | 2010-12-28 | Mannkind Corporation | Dry powder inhaler |
USD629505S1 (en) | 2008-12-01 | 2010-12-21 | Mannkind Corporation | Dry powder inhaler |
USD635242S1 (en) | 2008-12-01 | 2011-03-29 | Mannkind Corporation | Dry powder inhaler |
USD629506S1 (en) | 2008-12-01 | 2010-12-21 | Mannkind Corporation | Dry powder inhaler |
USD629888S1 (en) | 2008-12-01 | 2010-12-28 | Mannkind Corporation | Dry powder inhaler |
USD635243S1 (en) | 2008-12-01 | 2011-03-29 | Mannkind Corporation | Dry powder inhaler |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
WO2010078373A1 (en) | 2008-12-29 | 2010-07-08 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
SI2379100T1 (sl) | 2009-01-08 | 2015-02-27 | Mannkind Corporation | Zdravljenje hiperglikemije z GLP-1 |
US8550074B2 (en) | 2009-01-15 | 2013-10-08 | Manta Devices, Llc | Delivery device and related methods |
TWI528982B (zh) | 2009-03-04 | 2016-04-11 | 曼凱公司 | 改良的乾粉藥物輸送系統 |
PL2405963T3 (pl) | 2009-03-11 | 2014-04-30 | Mannkind Corp | Urządzenie, układ i sposób pomiaru oporu inhalatora |
US8508732B2 (en) | 2009-03-18 | 2013-08-13 | Mannkind Corporation | Inhaler adaptor for a laser diffraction apparatus and method for measuring particle size distribution |
GB0907425D0 (en) | 2009-04-29 | 2009-06-10 | Glaxo Group Ltd | Compounds |
USD628090S1 (en) | 2009-05-07 | 2010-11-30 | Mccormick & Company, Incorporated | Seasoning package |
USD620375S1 (en) | 2009-05-11 | 2010-07-27 | Mcneil-Ppc, Inc. | Blister |
WO2010135672A1 (en) | 2009-05-21 | 2010-11-25 | Microdose Therapeutx, Inc. | Rotary cassette system for dry powder inhaler |
MY172858A (en) | 2009-06-12 | 2019-12-12 | Mannkind Corp | Diketopiperazine microparticles with defined isomer contents |
KR20180079458A (ko) | 2009-06-12 | 2018-07-10 | 맨카인드 코포레이션 | 한정된 비표면적을 갖는 디케토피페라진 마이크로입자 |
US9180263B2 (en) | 2009-07-01 | 2015-11-10 | Microdose Therapeutx, Inc. | Laboratory animal pulmonary dosing device |
US8642548B2 (en) | 2009-08-07 | 2014-02-04 | Mannkind Corporation | Val (8) GLP-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome |
WO2011031564A2 (en) | 2009-08-27 | 2011-03-17 | Stc.Unm | Methods and systems for dosing and coating inhalation powders onto carrier particles |
IT1395945B1 (it) | 2009-09-30 | 2012-11-02 | Oliva | Inalatore perfezionato per preparati in polvere |
USD647195S1 (en) | 2009-10-09 | 2011-10-18 | Vectura Delivery Devices Limited | Inhaler having cover |
USD647196S1 (en) | 2009-10-09 | 2011-10-18 | Vectura Delivery Devices Limited | Inhaler having cover |
EP2496295A1 (en) | 2009-11-03 | 2012-09-12 | MannKind Corporation | An apparatus and method for simulating inhalation efforts |
USD650295S1 (en) | 2009-11-13 | 2011-12-13 | Avidiamed Gmbh | Blister pack for pharmaceuticals |
USD641076S1 (en) | 2010-03-26 | 2011-07-05 | Oriel Therapeutics, Inc. | Dry powder inhaler |
PT105065B (pt) | 2010-04-26 | 2012-07-31 | Hovione Farmaciencia S A | Um inalador simples de cápsulas |
USD645954S1 (en) | 2010-05-21 | 2011-09-27 | Consort Medical Plc | Mechanical dosage counter apparatus |
USD636868S1 (en) | 2010-06-14 | 2011-04-26 | Mannkind Corporation | Dry powder inhaler |
USD636867S1 (en) | 2010-06-14 | 2011-04-26 | Mannkind Corporation | Dry powder inhaler |
USD636869S1 (en) | 2010-06-14 | 2011-04-26 | Mannkind Corporation | Dry powder inhaler |
RU2531455C2 (ru) | 2010-06-21 | 2014-10-20 | Маннкайнд Корпорейшн | Системы и способы доставки сухих порошковых лекарств |
CN101851213A (zh) | 2010-06-21 | 2010-10-06 | 于清 | 3,6-双(4-双反丁烯二酰基氨丁基)-2,5-二酮哌嗪及其盐取代物的合成方法 |
USD643308S1 (en) | 2010-09-28 | 2011-08-16 | Mannkind Corporation | Blister packaging |
ES2732818T3 (es) | 2010-11-09 | 2019-11-26 | Mannkind Corp | Composición que comprende un agonista de receptores de serotonina y una dicetopiperazina para tratar migrañas |
USD642483S1 (en) | 2010-12-03 | 2011-08-02 | Mccormick & Company, Incorporated | Seasoning package |
EP2673265B1 (en) | 2011-02-10 | 2016-10-19 | MannKind Corporation | Formation of n-protected bis-3,6-(4-aminoalkyl) -2,5,diketopiperazine |
CN105667994B (zh) | 2011-04-01 | 2018-04-06 | 曼金德公司 | 用于药物药盒的泡罩包装 |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
USD674893S1 (en) | 2011-10-20 | 2013-01-22 | Mannkind Corporation | Inhaler device |
AU2012328885B2 (en) | 2011-10-24 | 2017-08-31 | Mannkind Corporation | Methods and compositions for treating pain |
KR20150023315A (ko) | 2012-04-27 | 2015-03-05 | 맨카인드 코포레이션 | 에틸푸마레이트의 합성방법 및 중간체로서의 이들의 용도 |
CN108057154B (zh) | 2012-07-12 | 2021-04-16 | 曼金德公司 | 干粉药物输送系统和方法 |
US20150231067A1 (en) | 2012-08-29 | 2015-08-20 | Mannkind Corporation | Method and composition for treating hyperglycemia |
US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
CA2906817C (en) | 2013-03-15 | 2022-01-18 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
US9925144B2 (en) | 2013-07-18 | 2018-03-27 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
JP2016530930A (ja) | 2013-08-05 | 2016-10-06 | マンカインド コーポレイション | 通気装置及び方法 |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
-
2006
- 2006-01-10 US US11/329,686 patent/US9006175B2/en not_active Expired - Fee Related
- 2006-03-31 ES ES06740427T patent/ES2334258T3/es active Active
- 2006-03-31 EP EP20100075436 patent/EP2364717A1/en not_active Withdrawn
- 2006-03-31 DK DK06740427T patent/DK1909826T3/da active
- 2006-03-31 JP JP2008504512A patent/JP5719099B2/ja active Active
- 2006-03-31 US US11/278,381 patent/US7943572B2/en not_active Expired - Fee Related
- 2006-03-31 DE DE602006003228T patent/DE602006003228D1/de active Active
- 2006-03-31 AT AT06740427T patent/ATE411040T1/de not_active IP Right Cessation
- 2006-03-31 EP EP20100005945 patent/EP2266597A1/en not_active Withdrawn
- 2006-03-31 MX MX2007012102A patent/MX2007012102A/es active IP Right Grant
- 2006-03-31 DK DK08075731T patent/DK2027870T3/da active
- 2006-03-31 AT AT08075731T patent/ATE471154T1/de not_active IP Right Cessation
- 2006-03-31 CA CA2601860A patent/CA2601860C/en active Active
- 2006-03-31 EP EP20080075731 patent/EP2027870B1/en not_active Not-in-force
- 2006-03-31 DE DE200660015005 patent/DE602006015005D1/de active Active
- 2006-03-31 CN CNA2006800104377A patent/CN101151047A/zh active Pending
- 2006-03-31 EP EP06740427A patent/EP1909826B1/en not_active Not-in-force
- 2006-03-31 BR BRPI0608271-8A patent/BRPI0608271A2/pt not_active Application Discontinuation
- 2006-03-31 ES ES08075731T patent/ES2362220T3/es active Active
- 2006-03-31 KR KR1020077025098A patent/KR101244028B1/ko active IP Right Grant
- 2006-03-31 AU AU2006230576A patent/AU2006230576B2/en active Active
- 2006-03-31 WO PCT/US2006/012366 patent/WO2006105501A2/en active Application Filing
-
2007
- 2007-09-23 IL IL186182A patent/IL186182A/en active IP Right Grant
-
2009
- 2009-08-18 HK HK09107619A patent/HK1128876A1/xx not_active IP Right Cessation
-
2011
- 2011-02-18 AU AU2011200675A patent/AU2011200675B9/en active Active
- 2011-03-31 US US13/077,361 patent/US20110183901A1/en not_active Abandoned
-
2012
- 2012-10-29 JP JP2012238430A patent/JP5788374B2/ja not_active Expired - Fee Related
-
2015
- 2015-02-04 JP JP2015020034A patent/JP2015110631A/ja active Pending
- 2015-03-05 US US14/639,860 patent/US9801925B2/en not_active Expired - Fee Related
-
2016
- 2016-03-11 JP JP2016048575A patent/JP2016147883A/ja active Pending
- 2016-12-13 US US15/377,641 patent/US20170087217A1/en not_active Abandoned
-
2020
- 2020-01-07 US US16/736,692 patent/US20200138912A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003503420A (ja) * | 1999-06-29 | 2003-01-28 | ファーマシューティカル ディスカバリー コーポレイション | ペプチドおよびタンパク質の薬学的因子の精製および安定化 |
JP5788374B2 (ja) * | 2005-03-31 | 2015-09-30 | マンカインド コーポレイション | 糖尿病治療における優れた血糖コントロール |
Non-Patent Citations (8)
Title |
---|
JPN6010065295; Diabetes Technol Ther Vol.4, 2002, pp.589-94 * |
JPN6010065296; Diabetologia Vol.44(Suppl.1), 2001, p.A212 * |
JPN6014002959; S.Steiner et al.: ''Technosphere/Insulin--proof of concept study with a new insulin formulation for pulmonary delivery'' Exp Clin Endocrinol Diabetes 2002;110(1), 17-21 * |
JPN6014002960; Lindner et al.: ''Increase in serum insulin levels is correlated with lung distribution after pulmonary delivery of T' Diabetologia 2003 No.46, A277 * |
JPN6014002961; 稲田千鶴子ら: ''インスリン療法'' 臨床と研究 72巻1号 (1995), 36-39 * |
JPN6014002962; 荒木栄一ら: ''インスリン療法の基本'' 臨床と研究 79巻1号 (2002), 38-42 * |
JPN6014002963; 岩本安彦: ''糖尿病治療のストラテジー'' 医学のあゆみ Vol.188, No.5 (1999), 472-476 * |
JPN6016032319; Uwaifo GI, Ratner RE: 'Novel pharmacologic agents for type 2 diabetes' Endocrinology and Metabolism Clinics of North America Vol.34, No.1, 20050304, p.155-197 * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200138912A1 (en) | Superior control of blood glucose in diabetes treatment | |
US20240197836A1 (en) | Method of treating diabetes type 2 by administering ultrarapid acting insulin | |
AU2006275424B2 (en) | Method of preserving the function of insulin-producing cells | |
De Galan et al. | Efficacy and safety of inhaled insulin in the treatment of diabetes mellitus | |
Hollander | Evolution of a pulmonary insulin delivery system (Exubera) for patients with diabetes | |
US11980656B2 (en) | Method of treating hypoglycemia events in diabetes treatment | |
AU2012203626B2 (en) | Superior control of blood glucose in diabetes treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150916 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20151215 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160311 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160830 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20161129 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20170127 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170227 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20170307 |